seoul, april 25-27, 2007 · seoul, april 25-27, 2007 “please block the dates on your...

Seoul, April 25-27, 2007“Please block the dates on your calendar…”

SecretariatAngioplasty Summit 2006-TCT Asia Pacific388-1 Poongnap-2dong, Songpa-gu, Seoul, 138-736, KoreaTel: 82-2-3010-4799/4689 Fax: 82-2-475-6898E-mail: [email protected] / [email protected] l www.cvrf.org

0604

25

www.summitMD.com

Seo

ul,A

pril

Venu

e_Th

e C

onve

ntio

n C

ente

r of S

hera

ton

Gra

nde

Wal

kerh

ill H

otel

,S

eoul

, Kor

ea

Cha

nges

!R

eal T

ime

Lect

ures

by

Live

Sat

ellit

e Tr

ansm

issi

ons

Late

Bre

akin

g C

linic

al T

rials

Inte

rven

tiona

l Vas

cula

r Sim

ulat

ion

Cen

ter /

IVU

S L

earn

ing

Cen

ter

ww

w.s

umm

itMD

.co

m

FFiinnaall PPrrooggrraamm

Sponsored by

Angioplasty Summit 2006-TCT Asia Pacific Associations and AffiliationsCardioVascular Research Foundation (CVRF) / Asan Medical Center, Seoul, Korea Cardiovascular Research Foundation (CRF)/ Columbia University Medical Center, New York, USATranscatheter Cardiovascular Therapeutics (TCT)The Paris Course on Revascularization (EuroPCR)Complex Catheter Therapeutics (CCT)Asian Pacific Society of Interventional Cardiology (APSIC)The Korean Society of CirculationThe Korean Society of Interventional Cardiology The Korean Study Group of Pediatric Interventional CardiologyCardiovascular Technology Association (CTA)

Course DirectorsSeung-Jung Park, MD Gary S. Mintz, MD

Course Co- DirectorsJohn R. Laird, MDJean Marco, MD Seong-Wook Park, MDShigeru Saito, MDHideo Tamai, MDAlan C. Yeung, MD

Course DirectorsSeung-Jung Park, MD Gary S. Mintz, MD

Organizing CommitteeMyeong-Ki Hong, MDYang Soo Jang, MD Myung-Ho Jeong, MDHyo-Soo Kim, MDJae-Joong Kim, MDJae-Ki Ko, MDDong Joo Oh, MDKi Bae Seung, MDSeung-Jea Tahk, MDJoo-Young Yang, MD

Scientific CommitteeMaurice Buchbinder, MDCharles Chan, MDSeung-Yun Cho, MDGyu-Bo Choi, MDAntonio Colombo, MDRunlin Gao, MDJunbo Ge, MDEberhard Grube, MDHyeon-Cheol Gwon, MDYaling Han, MDMun Kyung Hong, MDYong Huo, MDIk-Kyung Jang, MDJung Chaee Kang, MDOsamu Katoh, MD

Scientific CommitteeKwon-Bae Kim, MDYoung-Jo Kim, MDSang Hoon Lee, MDYean-Leng Lim, MDJeffrey W. Moses, MDByung-Hee Oh, MDJeong Euy Park, MDYoung-Bae Park, MDTeguh Santoso, MDPatrick W. Serruys, MDEak-Kyun Shin, MDWon-Heum Shim, MDTakahiko Suzuki, MDTetsu Yamaguchi, MDJunghan Yoon, MD

TCT Asia Pacific Co-DirectorsMartin B. Leon, MDGregg W. Stone, MD

02 l

03 C

ours

e D

irec

tors

/ T

able

of C

onte

nts

Course Directors

Faculty

Meeting at a Glance

Focus

Live Case Transmission Sites

Program

Learning Center

Angioplasty Summit-TCT Asia pacific 2007

Oral Abstract Presentations

Poster Abstract Presentations

Abstract Graders

Acknowledgement

Exhibit / Learning Center Lay-Out

Venue Lay-Out

02

04

06

07

08

12

13141415

1617181921

22232325

26

27

28

29

45

46

47

48

Table of ContentsAngioplasty Summit 2006-TCT Asia Pacific

International Faculty

Korean Faculty

Wednesday, April 26 Main ArenaTutorial Auditorium ALunchtime ActivitiesEvening Satellite Symposia

Thursday, April 27 Main ArenaTutorial Auditorium ATutorial Auditorium BBreakfast MeetingsLunchtime Activities

Friday, April 28 Main Arena AMain Arena BBreakfast Meetings9th Annual Conference for Cardiovascular Nurse & Technologist

Seo

ul,

Ap

ril

26~

28, 2

006

Faculty

Takashi Akasaka, MDWakayama Medical University, Japan

Yaron Almagor, MDShaare Zedek Medical Center, Israel

Yasushi Asakura, MDKeio University School of Medicine, Japan

Suman Bhandari, MDEscorts Heart Institute, India

Giancarlo Biamino, MD Heart Center Leipzig, Germany

Raoul Bonan, MDMontreal Heart Institute, Canada

Charles Chan, MDGleneagles Medical Centre, Singapore

Kam Tim Chan, MDQueen Elizabeth Hospital, Hong Kong, China

Paul Chan, MDTaipei Medical University Wan Fang Hospital,Taiwan

Wai Kwong Chan, MDUnited Christian Hospital, Hong Kong, China

Fang Chen, MDBeijing Anzhen Hospital Capital University ofMedicine, China

Jilin Chen, MDFu Wai Hospital, China

Zhengming Chen, MDClinical Trial Service Unit, UK

Jun-Jack Cheng, MDShin Kong Hospital, Taiwan

Kenneth Chin, MDPantai Medical Centre, Malaysia

Chia-Yu Chou, MD Veterans General Hospital, Taiwan

Howard A. Cohen, MDLenox Hill Heart & Vascular Institute, USA

Antonio Colombo, MDColumbus Hospital, Italy

Gian Battista Danzi, MDOspedale Maggiore Policlinico University ofMilan, Italy

Hiroshi Domae, MD Shonan Kamakura General Hospital, Japan

Dariusz Dudek, MDJagiellonian University Medical College, Poland

Leif R. W. Erhardt, MDMalmö University Hospital, Sweden

Jean Fajadet, MDCardiologie Interventionelle Clinique Pasteur,France

Erling Falk, MDAarhus University Hospital, Denmark

Alfredo R. Galassi, MDInstitute of Cardiology University of Catania,Ferrarotto Hospital, Italy

D.S. Gambhir, MDKailash Heart Institute, India

Runlin Gao, MDFu Wai Hospital, China

Eulogio Garcia, MDHospital General Universitario GregorioMarañón, Spain

William A. Gray, MDNewYork-Presbyterian Hospital / ColumbiaUniversity Medical Center, USA

Eberhard Grube, MDHeart Center Siegburg, Germany

Martial Hamon, MDUniversity Hospital of Caen, France

Shirish Hiremath, MD Heart Care Clinic, India

Duncan Hung Kwong Ho, MDQueen Elizabeth Hospital, Hong Kong, China

David R. Holmes, Jr, MDMayo Clinic, USA

Junko Honye, MDNihon University School of Medicine, Japan

Mark Horrigan, MDAustin Health, Australia

Angela Hoye, MDCastle Hill Hospital, UK

I Chang Hsieh, MDChang Gung Memorial Hospital, Taiwan

Yong Huo, MDFirst Hospital Peking University, China

Keiichi Igarashi, MDHokkaido Social Insurance Hospital, Japan

Yuji Ikari, MD Tokai University School of Medicine, Japan

Naoto Inoue, MD Kyoto 2nd Red Cross Hospital, Japan

Ik-Kyung Jang, MDMassachusetts General Hospital, USA

Yoshifumi Kan, MDShin-Yukuhashi Hospital, Japan

David E. Kandzari, MDDuke Clinical Research Institution, USA

Paul Hsien-Li Kao, MDNational Taiwan University Hospital, Taiwan

Osamu Katoh, MDToyohashi Heart Center, Japan

Upendra Kaul, MDFortis Hospital, India

Mikihiro Kijima, MDHoshi General Hospital, Japan

Takeshi Kimura, MDKyoto University Hospital, Japan

Tarlochan Singh Kler, MDEscorts Heart Institute & Research Centre, India

Wolfgang Koenig, MD Ulm University Medical Center, Germany

Tien-Hai Koh, MDNational Heart Centre, Singapore

Jacques J. Koolen, MDCatharina Hospital Eindhoven, The Netherlands

Michael J.B. Kutryk, MDSt. Michael's Hospital, Canada

Vincent On-Hing Kwok, MDHong Kong Sanatorium & Hospital, HongKong, China

John R. Laird, Jr, MDWashington Hospital Center, USA

Kenneth K.H. Lam, MDBaptist Hospital, Hong Kong, China

Peter Jan Lansberg, MD Academic Medical Centre, The Netherlands

Michael Kang-Yin Lee, MDQueen Elizabeth Hospital, Hong Kong, China

Thierry Lefèvre, MDInstitut Hospitalier Jacques Cartier, France

Martin B. Leon, MDNewYork-Presbyterian Hospital / ColumbiaUniversity Medical Center, USA

Shu Kin Li, MDPamela Youde Nethersole Eastern Hospital,Hong Kong, China

Yean-Leng Lim, MDUniversity of Melbourne, Australia

Yean-Teng Lim, MDNational University Hospital, Singapore

Shuzheng Lu, MD Beijing Anzhen Hospital, China

Josef Ludwig, MD University Clinic, Germany

Motomaru Masutani, MDHyogo College of Medicine, Japan

Tetsuo Matsubara, MDToyohashi Heart Center, Japan

Roxana Mehran, MDNewYork-Presbyterian Hospital / ColumbiaUniversity Medical Center, USA

Bernhard Meier, MD Swiss Cardiovascular Center Bern,Switzerland

Gary S. Mintz, MDCardiovascular Research Foundation, USA

Kazuaki Mitsudo, MDKurashiki Central Hospital, Japan

Yusuke Miyashita, MDShonan Kamakura General Hospital, Japan

Marie-Claude Morice, MDInstitut Hospitalier Jacques Cartier, France

Jeffrey W. Moses, MDNewYork-Presbyterian Hospital / ColumbiaUniversity Medical Center, USA

Ajit Sankardas Mullasari, MDMadras Medical Mission Hospital, India

Toshiya Muramatsu, MDKawasaki Social Insurance Hospital, Japan

Masato Nakamura, MDToho University Ohashi Hospital, Japan

Shigeru Nakamura, MDKyoto Katsura Hospital, Japan

Sunao Nakamura, MDNew Tokyo Hospital, Japan

Richard Ng, MDMount Elizabeth Medical Center, Singapore

Swee Choon Ng, MD Interventional Cardiovascular Society ofMalaysia, Malaysia

Masahiko Ochiai, MDShowa University Northern YokohamaHospital, Japan

Takashi Okada, MDNantan General Hospital, Japan

Marulam Panggabean, MD University of Indonesia Medical School,Indonesia

Ian M. Penn, MD Vancouver General Hospital, Canada

Otte J. Rachman, MD National Cardiac Centre Harapan KitaJakarta, Indonesia

Nicolaus J. Reifart, MD Main Taunus Heart Institute, Germany

Alfredo Rodriguez, MDOtamendi Hospital, Argentina

Mohd Ali Rosli, MDNational Heart Institute, Malaysia

InternationalInvited Faculty

04 l 05 Faculty_International Faculty

Barry D. Rutherford, MD Mid America Heart Institute, USA

Shigeru Saito, MDShonan Kamakura General Hospital, Japan

Ramesh S. Saligrama, MDRamesh Cardiology Associates, India

Teguh Santoso, MDUniversity of Indonesia Medical SchoolMedistra Hospital, Indonesia

Erick Schampaert, MDHôspital du Sacre-Coeur de Montréal,Canada

Dierk Scheinert, MDHeart Center Leipzig, Germany

Germano Di Sciasio, MD Universita Campus Biomedico, Italy

Peter Sever, MD Imperial College London, UK

Samin Sharma, MDMount Sinai Hospital, USA

Marc Silvestri, MD Private Hospital Parc Rambot, France

Kui-Hian Sim, MD Sarawak General Hospital, Malaysia

Robert J. Sommer, MD NewYork-Presbyterian Hospital / ColumbiaUniversity Medical Center, USA

J. Eduardo M.R. Sousa, MDInstitute Dante Pazzanese of Cardiology,Brazil

Christodoulos Stefanadis, MDAthens Medical School, Greece

Gregg W. Stone, MDNewYork-Presbyterian Hospital/ColumbiaUniversity Medical Center, USA

Satoru Sumitsuji, MDNozaki Tokushukai Hospital, Japan

Harry Suryapranata, MDIsala Clinics Hospital de Weezenlanden &Sophia Hospital, The Netherlands

Takahiko Suzuki, MDToyohashi Heart Center, Japan

Hideo Tamai, MDKusatsu Heart Center, Japan

Huay Cheem Tan, MDNational University Hospital, Singapore

Mitsuyasu Terashima, MD Toyohashi Heart Center, Japan

Damras Tresukosol, MDSiriraj Hospital, Thailand

Tak-Fu Tse, MD813 Medical Center, Hong Kong, China

Etsuo Tsuchikane, MDToyohashi Heart Center, Japan

Nguyen Quang Tuan, MD Vietnam National Heart Institute, Vietnam

Wasan Udayachalerm, MDSamitivej Hospital, Thailand

Kinzo Ueda, MD Rakuwakai Otowa Hospital, Japan

Takafumi Ueno, MD Fukuoka City Medical Association Hospital,Japan

D. Geoffrey Vince, PhDCleveland Clinic / Volcano Corporation, USA

Renu Virmani, MDCV Path, International Registry of Pathology, USA

Ron Waksman, MDWashington Hospital Center, GeorgetownUniversity, USA

Kai C. Wollert, MDMedizinische Hochschule Hannover,Germany

Philip Wong, MD National Heart Center, Singapore

Chiung-Jen Wu, MDChang-Gung Memorial Hospital, Taiwan

Takehiro Yamashita, MDHokkaido Ohno Hospital, Japan

Yuejin Yang , MDFu Wai Hospital, China

Alan C. Yeung, MDStanford University Medical Center, USA

Chun Yuan, MDUniversity of Washington, USA

Robaayah Zambahari, MDNational Heart Institute, Malaysia

Roberto Baglini, MD University of Pittsburgh Medical Centre, Italy

Vinay Kumar Bahl, MD All India Institute of Medical Sciences, India

Hemang Baxi, MD Heart Care Clinic, India

Bambang Budiono, MD Dr. Wahidin Sudirohusodo Hospital,Indonesia

Chi Kin Chan, MD Pamela Youde Nethersole Eastern Hospital,Hong Kong, China

Praveen Chandra, MDMax Devki Devi Heart and Vascular Institute, India

Subhash Chandra, MDNarinder Mohan Hospital & Heart Centre,India

Yun-dai Chen, MDBeijing Anzhen Hopital,China

Duc Huy Dinh, MD Heart Institute, Vietnam

Dennis Donohoe, MD Cordis Corporation, USA

Radka Duchonova, MDUniversity Hospital Motol, Prague, CzechRepublic

Guy Friedrich, MD University Hospital Innsbruck, Austria

Xianghua Fu, MD 2nd Hospital Affiliated Hebei MedicalUniversity, China

Massoud Ghasemi, MD Research Center of EndovascularIntervention / Sasar Hospital, Iran

Anupam Goel, MD Max Devki Devi Heart and Vascular Institute,India

Pravin K. Goel, MDSanjay Grandhi Pgims, India

Saurab Goel, MDCumballa Hill Hospital and Heart Institute,India

Bal Krishna Goyal, MDBombay Hospital and Medical ResearchCentre, India

Lijun Guo, MD PeKing University Third Hospital, China

Vivek Gupta, MD Indraprastha Apollo Hosptials, India

Ichiro Hamanaka, MD Rakuwakai Otowa Hospital, Japan

Takatoshi Hayashi, MDHimeji Cardiovascular Center, Japan

Ben He, MDRenji Hospital Affiliated to Shanghai JiaotongUniversity, China

Alberto Hendler, MD Assaf Harofeh Medical Center, Israel

Pramod Jaiswal, MD International Centre for Cardio Thoracic andVascular Diseases, India

Azhar Mahmud Kiani, MDArmed Forces Institute of Cardiology,Pakistan

Anil Kumar, MD Bombay Hospital and Medical ResearchCenter, India

Kai Huat Lam, MDNational Heart Institute, Malaysia

Weimin Li, MDFirst Affiliated Hospital Harbin MedicalUniversity, China

Kunihiko Makino, MD Toho University Ohashi Medical Center,Japan

Sanjay Mehrotra, MD Narayana Hrudayalaya Bangalore, India

N.A.M Momenuzzaman, MDNational Heart Foundation Hospital &Research Institute, Bangladesh

Naohiko Nakanishi, MD Kyoto Second Red Cross Hospital, Japan

Hajime Nakaoka, MD Rinku General Medical Center, Japan

Kenya Nasu, MDToyohashi Heart Center, Japan

Tommy Ng, MD Deborah Heart and Lung Center, USA

Yoichi Nozaki, MD Hokko Memorial Hospital, Japan

Masaaki Okutsu, MD Rinku General Medical Center, Japan

Wenyue Pang, MD Second Affiliated Hospital of China MedicalUniversity, China

Jayesh S. Prajapati, MDU.N. Mehta Institute of Cardiology andResearch Centre, India

Afzalur Rahman, MD National Institute of Cardiovascular Diseases,Bangladesh

Makoto Sato, MD Rinku General Medical Center, Japan

Gunasekaran Sengottuvelu, MDSri Ramachandra Medical College &Research Institute, India

Sumeet Sethi, MD Max Devki Devi Heart and Vascular Institute, India

Mridul Sharma, MD Delhi Heart & Lung Institute, India

Chao-Yang Soon, MDNational University Hospital, Singapore

Arun Srinivas, MDVikram Hospital & Heart Care, India

Krishnaswamy Subramanyan, MDApollo Hospitals, India

Akihiko Takahashi, MD Sakurakai Takahashi Hospital, Japan

Takashi Tanigawa, MDMie University Medical School Hospital, Japan

Tak-Sun Tse, MD Pamela Youde Nethersole Eastern Hospital,Hong Kong, China

2006 Faculty of the Year

Suresh G. Vijan, MD Wockhardt Heart Hospital, India

Haichang Wang, MD Xijing Hospital, China

Qiong Wang, MD Xijing Hospital, China

J.W. Van Werkum, MDSt. Antonius Hospital Nieuwegein, TheNetherlands

Masahisa Yamane, MD Ashikaga Red Cross Hospital, Japan

Wei-Hsian Yin, MD Cheng-Hsin General Hospital, Taiwan

Xuchen Zhou, MDFirst Affiliated Hospital Dalian MedicalUniversity, China

Taehoon Ahn, MD Gil Medical Center

Young-Keun Ahn, MD Chonnam National University Hospital

In-Ho Chae, MDSeoul National University Bundang Hospital

Jei Keon Chae, MDChonbuk National University Hospital

Sang-Sig Cheong, MDGangneung Asan Hospital

Seung-Yun Cho, MDYonsei University Severance Hospital

Hyun Min Choe, MD Wonju Christian Hospital

Yoon Haeng Cho, MDSoon Chun Hyang University Bucheon Hospital

Dong Hoon Choi, MDYonsei University Severance Hospital

Dong Ju Choi, MD Seoul National University Bundang Hospital

Gyu-Bo Choi, MD The Catholic University of Korea, St. Mary's Hospital

So-Yeon Choi, MD Ajou University School

Kook-Jin Chun, MDPusan National University Hospital

Nam Sik Chung, MD Yonsei University Severance Hospital

Woo-Young Chung, MD Seoul National University Bundang Hospital

Wook-Sung Chung, MD The Catholic University of Korea, St. Mary's Hospital

Hyeon-Cheol Gwon, MDSamsung Medical Center

Ki Hoon Han, MDAsan Medical Center

Kyoo-Rok Han, MD Hallym Kangdong Sacred Heart Hospital

Seung Hwan Han, MD Gil Hospital, Gachon Medical School

Jung Ho Heo, MD Kosin University Hospital

Myeong-Ki Hong, MDAsan Medical Center

Taeg Jong Hong, MD Pusan National University Hospital

Seung-Ho Hur, MD Keimyung University Dongsan Medical Center

Hweung Kon Hwang, MD Sejong Hospital

Yang-Soo Jang, MD Yonsei University Severance Hospital

Myung-Ho Jeong, MDChonnam National University Hospital

Sang-Ho Jo, MD Hallym University Sacred Heart Hospital

Jung Chaee Kang, MDChonnam National University Hospital

Chong-Jin Kim, MD Kyung Hee University East West Neo Medical Center

Do Il Kim, MD Inje University Pusan Baik Hospital

Dong Soo Kim, MD Inje University Pusan Baik Hospital

Duk-Kyung Kim, MD Samsung Medical Center

Hyo-Soo Kim, MD Seoul National University Hospital

Hyun Sook Kim, MD Chonbuk National University Hospital

Jae-Joong Kim, MD Asan Medical Center

Jeong Hyun Kim, MDHanyang University Medical Center

Jun Hong Kim, MD Pusan National University Hospital

Kee-Sik Kim, MDDaegu Catholic University Medical Center

Kwon-Bae Kim, MDKeimyung University Dongsan Medical Center

Moo Hyun Kim, MD Dong-A University Medical Center

Pum Joon Kim, MD Kangnam Saint Mary's Hospital

Seong-Ho Kim, MD Halla General Hospital

Young Dae Kim, MD Dong-A University Medical Center

Young Jo Kim, MD Yeungnam University Medical Center

Young-Hak Kim, MDAsan Medical Center

Jae-Ki Ko, MD Chonbuk National University Hospital

Young Guk Ko, MDYonsei University Severance Hospital

Bon-Kwon Koo, MD Seoul National University Hospital

Hyuckmoon Kwon, MD Yonsei University Severance Hospital

Cheol Whan Lee, MD Asan Medical Center

Dong Yeub Lee, MD Kyungpook National University Hospital

Jae-Hwan Lee, MD Chungnam National University Hospital

Keun Lee, MDSeoul Veterans Hospital

Nae Hee Lee, MD Soon Chun Hyang University Bucheon Hospital

Sang Gon Lee, MDUlsan University Hospital

Sang Hoon Lee, MD Samsung Medical Center

Seung-Hwan Lee, MD Yonsei University Wonju Christian Hospital

Seung-Whan Lee, MD Soon Chun Hyang University Bucheon Hospital

Sung Yun Lee, MD Inje University Ilsan Paik Hospital

Sang Wook Lim, MDBundang Cha Medical Center

Sang Yup Lim, MD Jeju University Hospital

Deuk Young Nah, MDDongguk University Kyongju Hospital

June Namgung, MD Inje University Ilsan Paik Hospital

Byung-Hee Oh, MDSeoul National University Hospital

Dong Joo Oh, MDKorea University Kuro Hospital

Chang-Kyu Park, MD Korea University Kuro hospital

Hoon Ki Park, MDSeoul Veterans Hospital

Hun Sik Park, MDKyungpook National University Hospital

Jae Hyeong Park, MDChungnam National University Hospital

Jeong Bae Park, MD Samsung Cheil Hospital

Jeong Euy Park, MD Samsung Medical Center

Keum Soo Park, MDInha University Hospital

Seong-Wook Park, MD Asan Medical Center

Seung-Jung Park, MDAsan Medical Center

Yongwhi Park, MD Kyungpook university hospital

Young-Bae Park, MD Seoul National University Hospital

In-Whan Seong, MD Chungnam National University Hospital

Ki Bae Seung, MDThe Catholic University of Korea, St. Mary's Hospital

Won-Heum Shim, MDYonsei University Severance Hospital

Eak-Kyun Shin, MD Gil Medical Center

Eun-Seok Shin, MD Ulsan University Hospital

Jae-Kwan Song, MD Asan Medical Center

Dae Chul Suh, MDAsan Medical Center

Kyu Bo Sung, MDAsan Medical Center

Seung-Jea Tahk, MDAjou University Medical Center

Joo-Young Yang, MDNHIC Ilsan Hospital

Tae-Hyun Yang, MD Inje University Busan Paik Hospital

Hyun Ki Yoon, MDAsan Medical Center

Junghan Yoon, MD Yonsei University Wonju Christian Hospital

Korean

06 l 07 Faculty_Korean / Meeting at a Glance

Mee

ting

at a

Gla

nce

Exhi

bit

Exhi

bit

Inte

rven

tiona

l Vas

cula

r Sim

ulat

ion

Cen

ter /

IVU

S Le

arni

ng C

ente

r

Inte

rven

tiona

l Vas

cula

r Sim

ulat

ion

Cen

ter /

IVU

S Le

arni

ng C

ente

r

Exhi

bit

Inte

rven

tiona

l Vas

cula

r Sim

ulat

ion

Cen

ter /

IVU

S Le

arni

ng C

ente

r

Tec

hnic

al F

orum

ILi

ve C

ases

& L

ectu

res

7:00

AM

7:30

AM

8:00

AM

8:30

AM

9:00

AM

9:30

AM

10:0

0 AM

10:3

0 AM

11:0

0 AM

11:3

0 AM

12:0

0 PM

12:3

0 PM

1:00

PM

1:30

PM

2:00

PM

2:30

PM

3:00

PM

3:30

PM

4:00

PM

4:30

PM

5:00

PM

5:30

PM

6:00

PM

6:30

PM

7:00

PM

7:30

PM

8:00

PM

8:30

PM

9:00

PM

Mai

n Ar

ena

Tut

oria

l Aud

itoriu

m A

Post

er A

bstr

acts

Lear

ning

Cen

ter

Exhi

bit

Mai

n Ar

ena

Tut

oria

l Aud

itoriu

m A

Tut

oria

l Aud

itoriu

m B

Post

er A

bstr

acts

Lear

ning

Cen

ter

Exhi

bit

Mai

n Ar

ena

A

Mai

n Ar

ena

B

Lear

ning

Cen

ter

Exhi

bit

Wed

nesd

ay,A

pril

26

Thu

rsda

y, A

pril

27

Frid

ay,

Apr

il 28

TC

T A

PLi

ve C

ases

& S

atel

lite

Lect

ures

, & D

ES S

umm

it I

Live

Cas

es &

Ple

nary

Ses

sions

Live

Cas

es &

Ple

nary

Ses

sions

Lat

e B

reak

ing

Clin

ical

Tri

als

Live

Cas

es &

Ple

nary

Ses

sions

Tec

hnic

al F

orum

III

Live

Cas

es &

Lec

ture

s

Lunc

htim

eAc

tiviti

es

Lunc

htim

eAc

tiviti

es

Post

er A

bstr

act

Pres

enta

tion

#1

Post

er A

bstr

act

Pres

enta

tion

#3Po

ster

Abs

trac

tPr

esen

tatio

n #2

Brea

kfas

tM

eetin

gs

Brea

kfas

tM

eetin

gs

Bes

t Cas

ePr

esen

tatio

nsT

echn

ical F

orum

II (T

RI)

Live

Cas

es &

Lec

ture

s

Hot

Top

ics

APSI

CC

CT

Euro

PCR

9th

Ann

ual C

onfe

renc

e fo

r C

ardi

ovas

cula

r N

urse

& T

echn

olog

ist

Cas

e Pr

esen

tatio

ns w

ith th

e Ex

pert

s’ R

evie

w

DES

Sum

mit

IVV

ulne

rabl

e Pl

aque

Ses

sion

Even

ing

Sym

posia

Focus

Tutorial Auditorium AWednesday, April 26, 3:00 PM ~ 6:00 PM

Thursday, April 27, 9:30 AM ~ 6:30 PM

How to-What to“More practical” “More technical”

Technical Forums

- Live Case Demonstrations

- State-of-the-Art Lectures

Tutorial Auditorium BThursday, April 27, 9:30 AM ~ 5:30 PM

Hot Topic Series: Clinical Controversies and Debateson topics related to the specific lesioncharacteristics

Structural Heart Disease: Diagnosisand Interventional Approaches

Management of Long SFA, Aorta-Iliac Artery, Renal Artery, CarotidArtery, and Vertebral ArteryStenting, Cerebral Aneurysm

Lt. Main Interventions

Exclusive International Meetings &Society at Angioplasty Summit – TCT Asia Pacific

APSIC

CCT

EuroPCR

Concurrent Session

NewNew

New

Main ArenaWednesday,

April 26, 8:30 AM ~ 6:00 PM

Thursday,

April 27, 8:30 AM ~ 6:30 PM

Great Openingwith TCT-Asia Pacific :

- Wrapping up Clinical TrialUpdates from TCT, AHA,ACC

- Next Waves in DES

- Real Time Live Lectures andCases Transmission from CRF& Columbia UniversityMedical Center

Plenary SessionsState-of-the-Art Lecture Series by worldrenowned experts

Live Case SessionsLive Case Demonstrations featuringdifferent techniques by different operators inthe same type of lesions simultaneously

Late Breaking Clinical TrialsThe first presentations of the hot issue trialson the interventional cardiology

Great OpeningTCT Asia Pacific Session :

- Wrapping up Clinical TrialUpdates from TCT, AHA, ACC

- Next Waves in DES

- Real Time Live Lectures andCases Transmission from CRF& Columbia UniversityMedical Center

New

08 l 09 Focus

These sessions sponsored by CVRF and 12 industries,will complement the didactic material from the mainscientific sessions.

Evening SatelliteSymposiaApril 26, 6:00 PM ~ 9:00 PM

“Real Time Lecture by Live Satellite

Transmission”

What Makes DES Effective and Safe? - Cypher and Endeavor Experience

Co-sponsored by;

Johnson & Johnson Medical KoreaMedtronic, Inc.

Best Practice in DES to ImproveClinical OutcomeExpect More From Your DESCo-sponsored by;

Boston Scientific KoreaGuidant Korea

Breakfast Meetings April 27 ~ 28, 7:00 AM ~ 8:10 AM

Case Reviews: Meet the Experts “Mini-Lectures and CaseDiscussions”Providing participants with smallgroup environment of mini lecturesand the selected challenging casereviews with Breakfast

Left Main Intervention

Drug Eluting Stent Summit II, III

Bifurcation Lesion Intervention

Peripheral Lesion Intervention: Ilio-popliteal Artery, Infrapopliteal, SFA,Renal Artery

Complications

Cutting Edge Strategies in ACS and STElevation MI

Complex Lesion Intervention : Atheroablation, Thrombectomy, and DistalProtection

Noninvasive Imaging Is Changing theDiagnostic Paradigm for CAD: IVUS, CT, FFR

Chronic Total Occlusions

Structural Heart Disease: Congenital Valvular Disease, PFO, ASD,and Perivalvular Leaks

Lunchtime Activities IWednesday, April 26, 12:40 PM ~ 1:40 PM

Oral Abstract Presentations-Best AbstractsSponsored by

CardioVascular Research Foundation (CVRF)

Management Perspectives for thePrevention of AtherothromboticEvents in ACS PatientsSponsored by

Bristol-Myers Squibb Korea & Sanofi Aventis

Optimal Therapeutic Approach toPost PCI PatientsSponsored by Novartis Korea

Angiomyogenesis SymposiumSponsored by

CardioVascular Research Foundation (CVRF)

Managing the Vascular Puzzle ofCardiovascular Syndroms: How Do We Integrate Science andEvidence into PracticeSponsored by MSD Korea

Effects of Statin on Inflammation &Latest Atherosclerosis TrialSponsored by AstraZeneca Korea

Satellite SymposiaThese sessions sponsored by CVRF and 12 industries, will complementthe didactic material from the main scientific sessions.

New

Focus

Lunchtime Activities IIThursday, April 27, 12:30 PM ~ 1:30 PM

Trends & Issues in PeripheralCardiology

Sponsored by

Johnson & Johnson Medical Korea

The New HEALING Era with GenousSponsored by

OrbusNeich Medical Korea, Ltd.

Optimizing the Long-Term Preventionof Atherothrombotic Events

Sponsored by

Bristol-Myers Squibb Korea & Sanofi Aventis

AMS: Continuity in Proof of ConceptSponsored by BIOTRONIK GmbH & Co. KG

New Insights and TherapeuticApproaches to Lipid Management

Sponsored by Pfizer Pharmaceutical Korea Ltd.

Crossing the LesionSponsored by

TERUMO KOREA CORPORATION

Summit-TCT APAbstract PresentationsAll accepted abstracts are published both in asupplement issue of “The American Journal ofCardiology” and on www.summitMD.com.

Oral Abstract PresentationsApril 26, 12:40 PM ~ 1:40 PM

The outstanding 5 abstracts for theAngioplasty Summit 2006-TCT AsiaPacific will be presented during lunchtimeactivities.

Moderated Poster AbstractPresentations#1. April 26, 2:00 PM ~ 4:00 PM#2. April 27, 9:00 AM ~ 11:00 AM#3. April 27, 2:00 PM ~ 4:00 PM

These presentations moderated byworld-celebrated experts will honor thebest 15 abstracts for the meeting.

Poster Abstract PresentationsAll poster Abstracts will be available forviewing in the Exhibit Hall.

Best Challenging Case PresentationsApril 27, 9:30 AM ~ 10:30 AM

The best 5 challenging cases will bepresented and discussed with delegates at the Tutorial Auditorium A.

Case Presentations withthe Experts’ Review

April 28, 8:30 AM ~ 12:30 PM

At this session, the selected challengingcases for the meeting will be presentedwith the world-experts' review focusing onspecific lesion characteristics.

NewNew

NewNew

NewNew

10 l 11 Focus

HighlightSymposia

Drug Eluting Stent Summit

(The Present and Future)

Pathogenesis, Detection, and

Treatment of Vulnerable Plaque

Angiomyogenesis Symposium

Non-Invasive Cardiac Imaging

Structural Heart Disease

Peripheral Intervention

Cutting Edge Strategies in ACS

and AMI

Hot Topic Series

Antithrombin Alternatives and

Platelet Inhibition

Interventional Vascular Simulation cul

is designed for the Hands-On SimulatorExperience of the delegates at the meetingto assist real practices in their laboratory.The interventional experts and the technicalproctors will guide you into wholeprocedures.

Please refer to page 26

IVUS LearningCenter

leads the participants how to measure andclassify lesion characters by using IVUS intheir daily practice to make it more usefuland efficient. The trained technicalpracticians will welcome you to help.

Please refer to page 26

ExhibitOpen: April 26, 9:00 AM ~ 6:00 PM

April 27, 9:00 AM ~ 6:00 PM

April 28, 9:00 AM ~ 12:30 PM

An ideal and unique Pavilion of introducingthe emerging technology of this field andcommunicating with the participants at themeeting, by the world-leading industries,helps this educational event carry itsacademic goals.

9th AnnualConference forCardiovascular Nurse& Technologist

Organized by CardiovascularTechnology Association (CTA)

Friday, April 28, 12:30 PM ~ 3:15 PM

This symposium will provide theprofessionals devoted to thecardiovascular field with the lecturesinvolving the basic interventionalapproaches and physiologic guidance ofIVUS. There will be followed very interestingcase presentations with acidulousdiscussions from China, Japan and Koreaafter the didactic lectures.

Official Language

- English

SimultaneousTranslation Services

English into - Chinese

- Japanese

- Korean

InterventionalVascular SimulationCenter

Operators & IVUS InterpreterColumbia University Medical Center, New York, USA

Michael Collins, MD

William A. Gray, MD

Martin B. Leon, MD

Jeffrey W. Moses, MD

Robert J. Sommer, MD

Gregg W. Stone, MD

Giora Weisz, MD

Institut Hospitalier Jacques Cartier,Massy, France

Y. Louvard, MD

Marie-Claude Morice, MD

Toyohashi Heart Center, Aichi, Japan

Mariko Ehara, MD

Osamu Katoh, MD

Tetsuo Matsubara, MD

Takahiko Suzuki, MD

Hideo Tamai, MD

Mitsuyasu Terashima, MD

Etsuo Tsuckikane, MD

National University Hospital,Singapore

Ronald C. H. Lee, MD

Yean-Teng Lim, MD

Adrian Low, MD

Huay Cheem Tan, MD

Yonsei University SeveranceHospital, Seoul, Korea

Dong Hoon Choi, MD

Young Guk Go, MD

Yang-Soo Jang, MD

Toshiya Muramatsu, MD

Daegu Catholic University MedicalCenter, Daegu, Korea

Ji Yong Choi, MD

Seung-Ho Hur, MD

Kee-Sik Kim, MD

Jin Bae Lee, MD

Young Soo Lee, MD

Jong-Seon Park, MD

Jae Kean Ryu, MD

Shigeru Saito, MD

Asan Medical Center, Seoul, Korea

#1. Seung-Jung Park, MD, Seong-Wook Park, MDMyeong-Ki Hong, MD

#2. Seung-Jung Park, MD, Ki Bae Seung, MD

#3. Takeshi Kimura, MD, In-Ho Chae, MD

#4. Alan C. Yeung, MD, Teguh Santoso, MD

#5. Barry D. Rutherford, MD, Joo-Young Yang, MD

#6. Seung-Jung Park, MD, Seung-Jea Tahk, MD

#7. Jeffrey W. Moses, Robaayah Zambahari, MD

#8. Eberhard Grube, MD, Myung-Ho Jeong, MD

#9. Jean Fajadet, MD, Jei Keon Chae, MD

#10. Charles Chan, MD, Wook-Sung Chung, MD

#11. Kazuaki Mitsudo, MD, Yong Huo, MD

#12. Giancarlo Biamino, MD, Seong-Wook Park, MD

#13. John R. Laird, Jr, MD, Paul Hsien-Li Kao, MD

#14. William A. Gray, MD, Seong-Ho Kim, MD

#15. Seung-Jung Park, MD, Seong-Wook Park, MD,Myeong-Ki Hong, MD

#16. Ron Waksman, MD, Hyeon-Cheol Gwon, MD

#17. Nicolaus J. Reifart, MD, Junghan Yoon, MD

<IVUS Interpreter: Gary S. Mintz, MD>

Live Case Transmission Sites

12 l 13 Live Case Transmission Sites / Program

Program_Wednesday, April 26

10:20 AM Satellite Lecture:

A New View of theArchitecture of VulnerablePlaque (Size, Composition,and Distribution), andPathophysiologic InsightsInto Triggering MechanismsRenu Virmani

10:40 AM A Futuristic Vision of NextGeneration IntravascularUltrasound ImagingSystemsGary S. Mintz

11:00 AM Countdown to COMBAT Roxana Mehran

Drug Eluting Stent Summit - I

Moderators: Jeffrey W. MosesJ. Eduardo M.R. Sousa

11:10 AM Axxess Plus : The FirstDrug-Eluting Stent for theTreatment of BifurcationLesionsJeffrey W. Moses

11:25 AM SISR. A ProspectiveRandomized Comparisonof the Sirolimus-ElutingStent vs Brachytherapy inPatients with Bare MetalIn-Stent RestenosisDavid R. Holmes, Jr

11:40 AM Bioabsorbable Stents Jacques J. Koolen

11:55 AM DES in the Treatment of SVGJ. Eduardo M.R. Sousa

12:10 PM Technical Aspects and anUpdate on the EU and USZOMAXX Clinical TrialsAlan C. Yeung

12:25 PM ENDEAVOR-III: 1 YearResultsDavid E. Kandzari

12:40 PM Lunchtime ActivitiesPlease refer to page 14-15

WEDNESDAY,APRIL 26MAIN ARENAVista Hall, Level B2,8:30 AM~6:00 PM

8:30 AM Welcome AddressYung Woo Shin President, The Korean Society ofCirculation

8:35 AM Opening RemarkSeung-Jung Park

TCT ASIA PACIFICLive Case Transmission andFeatured Lectures from TCT

Live Case Session 1

Moderators: Gary S. Mintz Jeffrey W. Moses

Discussants: Charles ChanRunlin GaoEulogio GarciaYean-Leng LimRoxana MehranSeong-Wook ParkSeung-Jung ParkShigeru SaitoKi Bae SeungJ. Eduardo M.R. Sousa

8:40 AM Columbia UniversityMedical Center, New York,USA

Featured Lectures


New DES Clinical Trials: An Update from TCT, AHA,and ACCMartin B. Leon


PROSPECTS for theInvasive and NoninvasiveDiagnosis of VulnerablePlaque: Surveying theLandscape and Narrowingthe FieldGregg W. Stone

Live Case Session 2

Moderators: Yaron AlmagorNicolaus J. Reifart

Discussants: Jei Keon ChaeWai Kwong ChanBal Krishna GoyalLijun GuoYong HuoKazuaki MitsudoRichard NgMarulam PanggabeanHun Sik ParkTeguh Santoso

2:00 PM Asan Medical Center,Seoul, Korea Case #1

2:30 PM Toyohashi Heart Center,Aichi, Japan

3:00 PM Asan Medical Center,Seoul, Korea Case #2

State-of-the-Art Lectures 1

The CYPHER vs TAXUSControversyModerator: Wook-Sung Chung

3:30 PM The Preponderance ofData Favors CYPHER!David R. Holmes, Jr

3:45 PM Current Data Indicates NoClinically RelevantDifferences BetweenCYPHER and TAXUS!Eberhard Grube

Live Case Session 3Moderators: David R. Holmes, Jr

Alfredo Rodriguez

Discussants: Kenneth ChinKeiichi IgarashiTien-Hai KohJacques J. KoolenMichael Kang-Yin Lee N.A.M MomenuzzamanShigeru NakamuraMohd Ali RosliIn-Whan SeongRobert J Sommer

4:00 PM Yonsei UniversitySeverance Hospital, Seoul,Korea

4:30 PM Asan Medical Center,Seoul, Korea Cases #3, #4, #5

Program_Wednesday, April 26


Moderator: Ki Bae Seung

4:30 PM PCI and Distal InjurySeung-Jea Tahk

4:45 PM CTO: Wire (Standard andPro) Skills I: The Confianza(Conquest) WireKazuaki Mitsudo

Intensive Live Case Session 2

Moderators: Raoul BonanEberhard Grube

Discussants: Yasushi AsakuraSuman BhandariFang ChenShirish HiremathMark HorriganMyung-Ho JeongVincent On-Hing KwokSang Hoon Lee

5:00 PM Yonsei UniversitySeverance Hospital, Seoul,Korea

6:00 PM Adjourn

LUNCHTIME ACTIVITIES12:40 PM~1:40 PM

#1. Oral Abstract Presentations- Best Abstracts

Tutorial Auditorium A, Level 1

Sponsored by CardioVascular ResearchFoundation(CVRF)

Moderators: Seung-Jung ParkRon Waksman

12:40 PM Six-Month Outcome ofSirolimus-Eluting Stentwith Ticlopidine Anti-Platelet Regimen;Preliminary Analysis fromthe J-Cypher RegistryYoshihisa Nakagawa

12:52 PM Relationship BetweenPreprocedural High-Sensitivity C-ReactiveProtein and AdverseCardiac Events after Drug-Eluting Stent ImplantationDuk Woo Park

1:04 PM Prediction of Outcomeafter PercutaneousTransluminal SeptalMyocardial Ablation forHypertrophicCardiomyopathy withClinical, Echocardiographicand ProceduralCharacteristicsJM ten Berg

1:16 PM Plaque Modification BeforeTaxus Stent Implantation inUnfavorable Lesions:Results of the Rotablatorand/or Cutting Balloon toImprove Compliance,(ROCCO) StudyEulogio Garcia

1:28 PM Randomized Trial ofSirolimus- VersusPaclitaxel-Eluting Stentsfor the Treatment of AcuteST-Elevation MyocardialInfarctionJae-Hwan Lee

#2. Management Perspectives for thePrevention of AtherothromboticEvents in ACS Patients

Tutorial Auditorium B, Level 1

Sponsored by Bristol-Myers Squibb Korea& Sanofi Aventis

Moderator: Seong-Wook Park

12:40 PM Opening Address

12:45 PM Insights into STEMISeong-Wook Park

12:55 PM Optimising AntiplateletTherapy in Patients withSTEMI: Main Findings ofCLARITY and COMMITZhengming Chen

1:30 PM Q & A



5:30 PM New Aspects TreatingCritical Limb Ischemia Giancarlo Biamino

5:45 PM Carotid StentingJohn R. Laird, Jr

6:00 PM Adjourn

TUTORIALAUDITORIUM AMugunghwa Ballroom 1, Level 13:00 PM~6:00 PM

Technical Forum I : How to -What toNew Technique andTechnology: CTO and AMI Intervention


Moderator: Eak-Kyun Shin

3:00 PM Chronic Total Occlusions:Rationale forRecanalization, PatientSelection, and ResultsBarry D. Rutherford

3:15 PM Crossing the CTO - NewTechniques andTechnologiesJeffrey W. Moses


Moderators: Ik-Kyung Jang Jeffrey W. Moses

Discussants: Jun-Jack ChengHoward A. CohenKyoo-Rok HanJunko HonyeMikihiro KijimaShu Kin LiAjit Sankardas MullasariIan M. Penn

3:30 PM Toyohashi Heart Center,Aichi, Japan

14 l 15 Program

7:45 PM Q & A

8:00 PM Satellite Lecture:The Cypher and EndeavorDES Systems: New Clinical Trial Resultsand Future DirectionsMartin B. Leon

8:40 PM Q & A

9:00 PM Adjourn

#2. - Best Practice in DES to ImproveClinical Outcome

- Expect More From Your DES Tutorial Auditorium B, Level 1

Co-sponsored by Boston Scientific KoreaGuidant Korea

Moderators: Eulogio GarciaDong Joo Oh

Panelists: In-Ho ChaePraveen ChandraHyeon-Cheol GwonHweung Kon HwangMyung-Ho JeongMoo Hyun KimSeong-Wook ParkKrishnaswamy SubramanyanTak-Sun Tse

6:00 PM Dinner Reception &Welcome Address

6:40 PM SPIRIT FIRST 12-mthResults & XIENCE VCase ReviewEulogio Garcia

7:00 PM XIENCE V-The IdealCombination ofDeliverability, Efficacy &SafetyShigeru Saito

7:20 PM Taxus Liberté in Bifurcation Thierry Lefèvre

7:40 PM POET TrialYang-Soo Jang

8:00 PM Satellite Lecture:TAXUS Clinical ProgramUpdate Gregg W. Stone

8:20 PM Satellite Lecture:The Science Behind XienceGregg W. Stone

8:40 PM Q & A

9:00 PM Adjourn

#3. Optimal Therapeutic Approach toPost PCI Patients

Room 2-1

Sponsored by Novartis Korea

Moderator: Dong Joo Oh

12:40 PM Opening Address Dong Joo Oh

12:45 PM Lipid Treatment in Post PCIPatients Dong Hoon Choi

1:10 PM Medical Treatment for Patientswith Post-Myocardial Infarction- Importance of AngiotensinReceptor Blockers Yuji Ikari

1:35 PM Q & A

#4. Angiomyogenesis SymposiumRoom 2-2

Sponsored by CardioVascular ResearchFoundation(CVRF)

Moderator: Hyo-Soo Kim

12:40 PM Opening AddressHyo-Soo Kim

12:45 PM Application of ‘Bone MarrowMononuclear Cells’ for Ptswith MI; Lessons fromBOOST ProgramKai C. Wollert

1:10 PM Application of ‘MobilizedPeripheral BloodMononuclear Cells’ for Ptswith MI; Lessons fromMAGIC-CELL Program Hyo-Soo Kim

1:35 PM Q & A

#5. Managing the Vascular Puzzle ofCardiovascular Syndromes: HowDo We Integrate Science andEvidence into Practice

Room 3-1

Sponsored by MSD Korea

Moderator: Jae-Joong Kim

12:40 PM Opening Address Jae-Joong Kim

12:45 PM Integrating CV Risks:Beyond the BP Numbers Chang Kyu Park

1:10 PM The Cholesterol Balance:The Advanced Approach toDyslipidemia Management Peter Jan Lansberg

1:35 PM Q & A

#6. Effects of Statin on Inflammation &Latest Atherosclerosis Trial

Room 4-1

Sponsored by AstraZeneca Korea

Moderator: Nam Sik Chung


12:45 PM Surrogate Markers of CHD & Statins Wolfgang Koenig

1:10 PM Latest Atherosclerosis TrialKi Hoon Han

1:35 PM Q & A

EVENING SATELLITE SYMPOSIA6:00 PM~9:00 PM

#1. What Makes DES Effective andSafe? - Cypher and EndeavorExperience


Co-sponsored byJohnson & Johnson MedicalKorea / Medtronic, Inc.

Moderator: Seung-Jung ParkPanelists: Taehoon Ahn

Charles ChanHyo-Soo KimKai Huat LamKi Bae SeungSeung-Jea TahkJunghan YoonRobaayah Zambahari

6:00 PM Buffet Dinner

6:40 PM Welcome AddressSeung-Jung Park

6:45 PM Growing Body of Evidencein DES Bernhard Meier

7:00 PM The Perspectives ofZotarolimus(ABT-578) andPC TechnologyAlan C. Yeung

7:15 PM How To Differentiate DESDavid R. Holmes, Jr

7:30 PM DES Safety: The Hidden ConcernsDavid E. Kandzari

Program_Thursday, April 27

12:18 PM AMC-VIP Registry: VH-IVUS for PlaqueCharacterizationMyeong-Ki Hong

12:30 PM Lunchtime ActivitiesPlease refer to page 21

Live Case Session 6

Moderators: Eberhard GrubeBarry D. Rutherford

Discussants: Taehoon AhnDong Hoon ChoiJean FajadetAlfredo R. GalassiTakashi OkadaDierk ScheinertSamin SharmaEak-Kyun ShinTak-Fu TseTakehiro Yamashita

2:00 PM National UniversityHospital, Singapore,Singapore

2:30 PM Asan Medical Center,Seoul, Korea Cases #12, #13, #14


Moderator: Kwon-Bae Kim

3:30 PM Virtual Histology of AMI Barry D. Rutherford

3:45 PM Satellite Lecture: Update in BifurcationalLesions Treatment Antonio Colombo

THURSDAY,APRIL 277:00 AM Breakfast Meetings

Please refer to page 19-20

MAIN ARENAVista Hall, Level B2,8:30 AM~6:30 PM

Live Case Session 4

Moderators: Ron WaksmanAlan C. Yeung

Discussants: Vinay Kumar BahlRaoul BonanPaul ChanSang-Sig CheongWook-Sung ChungNaoto InoueHyuckmoon KwonErick SchampaertDamras TresukosolKinzo Ueda

8:30 AM Asan Medical Center, Seoul, Korea Cases #6, #7, #8

9:30 AM Daegu Catholic UniversityMedical Center, Daegu,Korea


Moderator: Dong Joo Oh

10:00 AM What Can 2D IVUS TeachUs About VulnerablePlaque?Gary S. Mintz

10:15 AM DES Thrombosis: Is It Realand Is It Worse? NewApproaches to Solving It ?David R. Holmes, Jr

Live Case Session 5

Moderators: David E. KandzariBernhard Meier

Discussants: Kam Tim ChanSubhash ChandraGian Battista DanziD.S. Gambhir Hweung Kon Hwang Yang-Soo Jang Roxana Mehran Masato Nakamura Seung-Jea Tahk Wasan Udayachalerm

10:30 AM Asan Medical Center, Seoul, Korea Cases #9, #10, #11

Late Breaking Clinical Trials

Moderators: David R. Holmes, JrJeffrey W. Moses

11:30 AM Percutaneous Treatmentof LONG Native CoronaryLesions with Drug-ElutingStents of Sirolimus-ElutingStent versus Paclitaxel-Eluting Stent: LONG-DES II StudyYoung-Hak Kim

11:42 AM Survival Advantage ofCABG over PCI in the RealWorld Clinical Practice; Is ItReal?: Insight from theCREDO-Kyoto PCI/CABGRegistryTakeshi Kimura

11:54 AM LONG Drug-ElutingStenting Followed byCilostazol TreatmentReduces LAte REstenosis:LONG-DECLARE Study Duk Woo Park

12:06 PM SPECIAL (Study ofProspective Events inCoronary IntermediateAtherosclerotic Lesions)TrialKenya Nasu

16 l 17 Program

Live Case Session 7

Moderators: Giancarlo BiaminoMarc Silvestri

Discussants: In-Ho Chae Howard A. CohenTarlochan Singh Kler Shuzheng Lu Swee Choon NgRamesh S. SaligramaGunasekaran SengottuveluSatoru SumitsujiPhilip WongJoo-Young Yang

4:15 PM Institut Hospitalier JacquesCartier, Massy, France

4:45 PM Asan Medical Center, Seoul, Korea Cases #15, #16, #17


Moderator: Young Jo Kim

5:45 PM Radiocontrast Nephropathy:Still the Achilles’ Heel ofInterventional Cardiology Roxana Mehran

6:00 PM Biolimus A9 Drug-ElutingStents: Technical Aspectsand a ComprehensiveReview of the EU, Asia-Pacific, and US NOBORIClinical Trial Program Eberhard Grube

6:15 PM Metallic BiodegradeableStentRon Waksman

6:30 PM Adjourn

TUTORIALAUDITORIUM AMugunghwa Ballroom 1, Level 19:30 AM~6:30 PM

Best Challenging Case Presentations

Moderators: John R. Laird, JrBarry D. Rutherford

Panelists: Yaron AlmagorHoward A. CohenTakeshi KimuraSeung-Jung ParkTeguh SantosoMarc Silvestri

9:30 AM Thrombo-Embolectomy inthe Superior Vena Cava andRight Atrium Using Angio-Jet and Balloon Occlusion Tommy Ng

9:45 AM DES Related RCA Aneurysm,Treated with Stent Graft withAcute Stent GraftThrombosis. What Next?Sumeet Sethi

10:00 AM Massive Arterial GraftDissection After BypassSurgery Bon-Kwon Koo

10:15 AM New CTO RecanalizationMethod-Retrograde GuideWire Penetration andRetrograde Balloon Dilatationin Combination withAntegrade PenetrationTechnique Qiong Wang

Technical Forum II : How to -What toTRI Club - Evolving Paradigm


Moderator: Junghan Yoon

Discussants: Hiroshi DomaeDuncan Hung Kwong HoYoshifumi KanDong Soo KimKenneth Ka-Hing LamJosef LudwigMotomaru MasutaniSamin SharmaChiung-Jen Wu

10:30 AM Daegu Catholic UniversityMedical Center, Daegu,Korea

TRI: Featured Lectures

11:30 AM Late Clinical andAngiographic Results ofCrush Stenting forBifurcation Lesions Yuejin Yang

11:45 AM CTO, Radial ApproachMartial Hamon

12:00 PM Novel Trial of PCI Trainingand Education -TRI VRSimulator DevelopmentThierry Lefèvre

12:15 PM Optimal Diployment ofStents for BifurcationLesions Using 3D CoronaryAngiographyJosef Ludwig


Technical Forum III : How to -What toNew Horisons for ComplexIntervention


Moderators: David E. KandzariSeung-Jung Park

2:00 PM Chronic Total Occlusions:Evidence Based Rationalefor Recanalization and DESDavid E. Kandzari

2:15 PM Unsolved Problems inCART and Septal DilationTechniqueOsamu Katoh

2:30 PM “I Need More Power,Scotty”: Guide CatheterSelection and ExpertBackup Techniques (Deep Engagement, Anchor, and More)Nicolaus J. Reifart

2:45 PM How to Penetrate theProximal and Distal FibrousCap in Chronic TotalOcclusion? Masahiko Ochiai


Hot Topic IIManagement of Long SFA, Aorta-Iliac Artery, Renal Artery, CarotidArtery, and Vertebral ArteryStenting, Cerebral Aneurysm

Moderators: Giancarlo BiaminoJohn R. Laird, Jr

10:30 AM Stenting of Long SFALesions UsingBioabsorbable StentsGiancarlo Biamino

10:42 AM Revascularization ofComplex Aorta-IliacObstruct Techniques andResultsDierk Scheinert

10:54 AM Does CerebrovascularReserve Affect Outcomesof Carotid Stenting? William A. Gray

11:06 AM Carotid and VertebralArtery StentingPaul Hsien-Li Kao

11:18 AM E-Clip: A New Way to TreatCerebral AneurysmsPercutaneouslyIan M. Penn

Hot Topic IIILt. Main Interventions

Moderators: Seung-Jung ParkMarc Silvestri

11:30 AM Percutaneous Treatment ofLeft Main Disease withPaclitaxel Drug ElutingStentsEulogio Garcia

11:42 AM French Pilot Registry ofUnprotected LM Stentingwith Taxus Stents, One YearFollow UpMarc Silvestri

11:54 AM Revised Protocol ofCOMBAT(RandomizedCOMparison of BypassSurgery versus AngioplasTyusing Sirolimus-ElutingStent in Patients with LeftMain Coronary ArteryDisease) Roxana Mehran


Moderators: Runlin Gao Takeshi Kimura

Discussants: Chia-Yu ChouKook-Jin ChunHyeon-Cheol GwonSunao NakamuraRichard NgKeum Soo ParkKui-Hian SimNguyen Quang Tuan

3:00 PM National UniversityHospital, Singapore,Singapore


Moderators: David R. Holmes, JrJeffrey W. Moses

4:00 PM Protection of Side BranchIs Essential in TreatingBifurcation Lesions:OverviewAlfredo R. Galassi

4:15 PM Bifurcation LesionIntervention Samin Sharma

4:30 PM Satellite Lecture:A Non-RandomizedComparison BetweenCABG and DES forUnprotected Left MainStenosis Antonio Colombo

4:45 PM Drug Eluting Stents(Bifurcation and Left MainApproach) Eberhard Grube

5:00 PM Treatment of In-StentRestenosisJ. Eduardo M.R. Sousa

5:15 PM What Are The Issues ofSurgical VersusPercutaneous Interventionfor Multivessel Disease?David R. Holmes, Jr


Moderators: David E. KandzariMichael J.B. Kutryk

Discussants: Taeg Jong HongI Chang HsiehPaul Hsien-Li KaoWeimin LiTetsuo MatsubaraMasahiko OchiaiOtte J. RachmanSuresh G. Vijan

5:30 PM Institut Hospitalier JacquesCartier, Massy, France

6:30 PM Adjourn

TUTORIAL AUDITORIUM BMugunghwa Ballroom 2, Level 19:30 AM~6:00 PM

Hot Topic IStructural Heart Disease: Diagnosis and Interventional Approaches

Moderators: Robert J. SommerBernhard Meier

9:30 AM Percutaneous Closure ofPerivalvular LeaksEulogio Garcia

9:42 AM InterventionalCatheterization for AdultCongenital Heart Disease Robert J. Sommer

9:54 AM Patent Foramen Ovale andMigraine: Does the DataJustify a Randomized Trialof Percutaneous Closurevs. Medical Therapy? William A. Gray

10:06 AM PFO Closure Now andTomorrow Bernhard Meier

10:18 AM Percutaneous Aortic ValveImplantationEberhard Grube

18 l 19 Program

7:50 AM Acute Total Occlusion ofthe Left Main Artery DuringCoronary AngiographyResulting in Cardiac Arrest& Its ManagementMassoud Ghasemi

8:00 AM Left Main CoronaryIntervention with ModifiedT Stenting in a Post CABGPatient with NonFunctioning LIMA to LADand Occluded SVG to OM Vivek Gupta

#2. Drug Eluting Stent Summit II Tutorial Auditorium B, Level 1

Moderators: Raoul BonanRon Waksman

7:00 AM A Prospective “All Comers”CYPHER NonrandomizedRegistry in ComplexPatients From MATRIXRoxana Mehran

7:10 AM Conor Erodable PolymerPaclitaxel Eluting Stent-Indian & EuropeanExperienceUpendra Kaul

7:20 AM Final Results From theORBIT Clinical TrialsRon Waksman

7:30 AM Endeavor ProgramRaoul Bonan

Case Presentations7:40 AM Strategies in Left Main

Coronary Artery Stenting ina Patient with Left MainStenosis and OccludedLADSanjay Mehrotra

7:50 AM Stent Thrombosis in LateIncomplete StentApposition After DESImplantation - What Should We Do?Sang-Ho Jo

12:06 PM LM Bifurcation InterventionGuideline for COMBATSeung-Jung Park

12:18 PM Clinical Outcomes forDrug-Eluting Stents in LMT LesionsToshiya Muramatsu


EXCLUSIVEINTERNATIONAL MEETINGS& SOCIETY ATANGIOPLASTY SUMMIT-TCT ASIA PACIFIC

APSIC Moderators: Yean-Leng Lim

Robaayah Zambahari

2:00 PM DES (Cypher) in DiabeticPatients; DECODE StudyCharles Chan

2:12 PM Trans Radial / BrachialApproach Carotid &Vertebral Stenting Chiung-Jen Wu

2:24 PM Saphenous Vein inInterventionsTarlochan Singh Kler

2:36 PM One-Year Follow-Up fromthe J-Cypher Registry Takeshi Kimura

2:48 PM PCI in Asia Pacific RegionRobaayah Zambahari

CCTThe Retrograde Approach -Special Techniques for CTOs from CCT Experts-

Moderators: Seung-Jung ParkTakahiko Suzuki

3:00 PM Key-Note Lecture: NewHorizon of CTO Intervention- Septal Dilation and CARTTechnique

Osamu Katoh

3:20 PM Lectures by Mikihiro Kijima,Masahiko Ochiai, YasushiAsakura, Masahisa Yamane

4:00 PM Q & A

EuroPCR Moderator: Jean Fajadet

4:30 PM Acute MIDariusz Dudek

4:45 PM Percutaneous PCI inDiabetic Patients Angela Hoye

5:00 PM Consensus and Questionsto Be Resolved inBifurcation Lesions Thierry Lefèvre

5:15 PM Medical Environment Post-PCI Germano Di Sciascio

5:30 PM Adjourn

Breakfast Meetings

Meet the Experts:Mini-Lectures and CaseDiscussions7:00 AM~8:10 AM

#1. Left Main Intervention Tutorial Auditorium A, Level 1

Moderators: Thierry Lefèvre Alan C. Yeung

7:00 AM How to Treat - UnprotectedLeft Main DiseaseSeung-Jung Park

7:10 AM DES in Left Main DiseaseThierry Lefèvre

7:20 AM Drug Eluting Stents for LeftMain TricksSunao Nakamura

7:30 AM PCI Using DES for LeftMain Stenosis in theElderlyAlan C. Yeung

Case Presentations7:40 AM Left Main Coronary Artery

Stenting in Situs InversusTotalis with Stable AnginaEun-Seok Shin


7:50 AM Aortic Dissection After PCIof Mid-RCA PCIJung Ho Heo

8:00 AM Catheter Induced De BakeyType II (Stanford Type A)Aortic Dissection withOcclusive Spral Dissectionof RCA and Perforation,Treated Non-SurgicallyTeguh Santoso

#6. Cutting Edge Strategies inACS and ST Elevation MI

Room 2-1

Moderators: Ik-Kyung JangHarry Suryapranata

7:00 AM AMI Intervention in DES Era Harry Suryapranata

7:10 AM Drug Eluting Stents in AMI Barry D. Rutherford

7:20 AM Intracellular CalciumModulation During AMIReperfusion: CASTEMI and EVOLVE Ik-Kyung Jang

7:30 AM Tirofiban and STEMIManagement: A Future Perspective.Gian Battista Danzi

Case Presentations7:40 AM Optimal Salvage of

Myocardium DuringPrimary PCI in Patient withAMISo-Yeon Choi

7:50 AM Hyperacute Thrombosis ofDrug Eluting StentArun Srinivas

8:00 AM Failed Thrombolysis atAcute Anterior WallMyocardial InfarctionAnil Kumar

8:00 AM Treatment of IatrogenicCoronary Artery Dissectionby Full Metal Jacket inRescue PCIHyun Min Choe

#3. Bifurcation Lesion InterventionRoom 3-1

Moderators: Yaron AlmagorNicolaus J. Reifart

7:00 AM Stent Platform forBifurcation Lesion in theDES EraDuncan Hung Kwong Ho

7:10 AM The Y-Med Sidekick Side-Branch Access StentYaron Almagor

7:20 AM Treatment of BifurcationLesionsKam Tim Chan

7:30 AM How to Treat Bifurcations Nicolaus J. Reifart

Case Presentations7:40 AM Thrombectomy Catheter

for Thrombotic Lesion: It Doesn't Work? It DoesWork? - A Case Where ItBoth Caused and Solvedthe ProblemChao-Yang Soon

7:50 AM Bifurcation LesionInterventionHaichang Wang

8:00 AM IVUS Guided DK-Crush(Double Kissing Crush) Cypher Stenting forBifurcation LesionMakoto Sato

#4. Peripheral LesionIntervention: Ilio-poplitealArtery, Infrapopliteal, SFA,Renal Artery

Room 2-2

Moderators: William A. Gray Seong-Wook Park

7:00 AM Interventional Treatment forIlio-popliteal Artery Disease Yusuke Miyashita

7:10 AM EndovascularManagement ofInfrapopliteal DiseaseGian Battista Danzi

7:20 AM Lower ExtremityRevascularization: a Data-Driven Approach toSFA Disease. William A. Gray

7:30 AM Renal Artery Stenosis inPatients with CoronaryArtery DiseaseIan M. Penn

Case Presentations7:40 AM Aortic Stent Graft

Exclusion of DissectingThoracic AneurysmAnupam Goel

7:50 AM Endovascular Repair forthe Pseudoaneurysm ofPopliteal Artery by PTFECovered StentNaohiko Nakanishi

8:00 AM A CHF Patient ProperlyManaged by Virtue of PCI& Bilateral Renal ArteriesStentingWoo-Young Chung

#5. Complications Room 4-1

Moderators: Hyeon-Cheol GwonVincent On-Hing Kwok

7:00 AM Stent Is More Critical Nowwith Drug Delivery Ian M. Penn

7:10 AM Bifurcation Stenting: the Return of Provisional T-stenting?Hyeon-Cheol Gwon

7:20 AM How to Treat DES FailureCases, Late StentMalapposition/Aneurysm? Vincent On-Hing Kwok

7:30 AM Complications Related tothe Use of RadiocontrastAgentsRoxana Mehran

Case Presentations7:40 AM 2 Cases of Coronary Artery

Perforation During PCIChi Kin Chan

20 l 21 Program

LUNCHTIME ACTIVITIES12:30 PM~1:30 PM

#7. Trends & Issues in PeripheralCardiology


Sponsored by Johnson & Johnson Medical Korea


12:30 PM Opening Remarks Seong-Wook Park

12:35 PM Peripheral Cardiology-Trends & Futures William A. Gray

12:50 PM SFA Stent Fractures - Its Clinical Impact and StentDesign Implication Dierk Scheinert

1:05 PM Renal Screening Programin Asian Context Shirish Hiremath

1:20 PM Q&A

#8. The New HEALING Era withGenous


Sponsored by OrbusNeich Medical Korea, Ltd.

Moderator: Seung-Jung Park

12:30 PM Opening AddressSeung-Jung Park

12:35 PM Endothelial Progenitor CellCapture Technology andResults of the HEALING IIStudyMichael J.B. Kutryk

12:50 PM Genous Bio-Engineered R-Stent: The Healing ClinicalDevelopment Program Harry Suryapranata

1:05 PM Neointimal DifferencesObserved via CoronaryAngioscopic Comparisionof Sirolimus-Eluting Stentand Bare Metal Stent Takefumi Ueno

1:20 PM Q & A Followed by ClosingRemarksSeung-Jung Park

#9. Optimizing the Long-TermPrevention of AtherothromboticEvents

Room 2-1

Sponsored by Bristol-Myers Squibb Korea &Sanofi Aventis

Moderator: Jeong Euy Park


12:35 PM REACH (The REduction ofAtherothrombosis forContinued-Health RegistryResults)Jeong Euy Park

12:50 PM The Role of AntiplateletTherapy in the Long-TermManagement ofAtherothrombosisZhengming Chen

1:20 PM Q&A

#10. AMS: Continuity in Proof ofConcept

Room 2-2

Sponsored by BIOTRONIK GmbH & Co. KG

Moderator: Yang-Soo Jang


12:35 PM Absorbable MetalStent(AMS): Technology,Clinical Update and FutureDevelopmentsMark Horrigan

1:20 PM Q & A followed by ClosingRemarks

#11. New Insights and TherapeuticApproaches to LipidManagement

Room 3-1

Sponsored by Pfizer Pharmaceutical Korea Ltd.

Moderator: Wook-Sung Chung

12:30 PM Opening Address Wook-Sung Chung

12:35 PM IDEAL: Safety and Efficacyof High Dose StatinsLeif R. W. Erhardt

12:55 PM Statin Difference: Lessons from OutcomeTrials Cheol Whan Lee

1:15 PM New Targets: The ChangingLandscape ofCardiovascular RiskManagementPeter Sever

1:35 PM Q&A

#12. Crossing the Lesion Room 4-1

Sponsored by TERUMO KOREACORPORATION

Moderators: Myung-Ho JeongThierry Lefèvre

12:30 PM Keynote Speech''Crossing the Lesion'' Myung-Ho Jeong

12:40 PM Retrograde Access for CTOMasahiko Ochiai

1:00 PM BifurcationThierry Lefèvre

1:20 PM Image Guided CTOSatoru Sumitsuji

1:40 PM Adjourn

FRIDAY,APRIL 287:00 AM Breakfast Meetings

Please refer to page 23-24

MAIN ARENA AVista Hall 1, Level B2,8:30 AM~12:30 PM

Case Presentation withExperts' Review: Lt. Main Intervention

Moderators: Seung-Jung ParkNicolaus J. Reifart

Panelists: Kee-Sik KimJacques J. KoolenToshiya MuramatsuMasato NakamuraAlan C.YeungXuchen Zhou

8:30 AM Primary PCI for AMI Patientwith Big Thrombus in theLeft MainSung Yun Lee

8:42 AM Drug Eluting Stent inAnomalous LMCA fromRight Coronary CuspHemang Baxi

8:54 AM Bifurcation Stenting with T-Stenting Technique inDistal Left Main Disease Seung-Whan Lee

9:06 AM Successful Provisional T-Stenting with CombinedUse of EPI-Filter and ExportAspiration Catheter inThrombus Containing LeftMain Bifurcation Lesion AsAcute Myocardial InfarctionSeung Hwan Han

9:18 AM A Case of Acute MyocardialInfarction: Crush Stentingfor Left Main BifurcationLesion After Debulking withRotablatorAkihiko Takahashi

Case Presentation withExperts' Review: Bifurcation Intervention

Moderators: Bernhard Meier Ki Bae Seung

Panelists: Osamu KatohKai Huat LamMasahiko OchiaiErick SchampaertAshok SethChiung-Jen Wu

9:30 AM Modified CrushingTechnique and DoubleKissing Balloon Dilatationfor Left Anterior DescendingArtery Bifurcation StenosisYun-dai Chen

9:42 AM Bifurcation Stenting Using aDedicaterd Bifurcation Stent(Twin Rail Stent)Pramod Jaiswal

9:54 AM Complex TRI Case IncludingTotal Occluded Lesion, DKCrush Cypher Stenting, SideBranch Occlusion, and WireRecross TroubleHajime Nakaoka

10:06 AM Treating In-Stent Restenosisof Kissing Stent in Left MainBifurcation with DESResulting in IncompleteCrushing Pum Joon Kim

10:18 AM Pitfall of Crush StentingKunihiko Makino

Case Presentation withExperts' Review: CTO Intervention

Moderators: Shigeru Saito Michael J.B. Kutryk

Panelists: Takashi AkasakaYong HuoYang-Soo JangUpendra KaulAlfredo RodriguezEtsuo Tsuchikane

10:30 AM A Case of Successful PCI ofRCA Ostial CTO Lesion withRetrograde ApproachThrough a Saphenous VeinGraftIchiro Hamanaka

10:42 AM The Successful Second Trialof Failed CTO Lesions inLAD and RCAYongwhi Park

10:54 AM IVUS Guided WiringTechnique in CTO-AnotherAspect of the TechniqueYoichi Nozaki

11:06 AM When PCI Fails in Antegradeand Retrograde Approach..Masahisa Yamane

11:18 AM Modified Crush StentTechnique for Proximal LADCTO with Bifurcation Lesionin Ostial D1Ben He

Case Presentation withExperts' Review: Complex Lesion Intervention

Moderators: Eberhard GrubeSeong-Wook Park

Panelists: Yasushi AsakuraJilin ChenRunlin GaoSeung-Hwan LeeThierry Lefèvre Seung-Jea Tahk

11:30 AM Percutaneous CoronaryIntervention in Octogenarianwith Multivessel DiseaseBambang Budiono

11:42 AM The Peep-Technique, aPossible Solution for Aorto-Ostial Stents Protruding intothe Aortic SinusAlberto Hendler

11:54 AM Combined Thrombo-Protection & Thrombo-Suction for Acute SVGOcclusion Intervention andCardiogenic ShockMridul Sharma

12:06 PM CTO of LAD with TandemSevere Disease in SomeWhat Anomoulus RCATackled with Shinobi Wire &Balloon Anchor for HookingRCA for Better SupportPravin K. Goel

Program_Friday, April 28

Pathogenesis, Detection, andTreatment of Vulnerable PlaqueSponsored by Clinical Research Center for

Ischemic Heart disease, TheKorea Ministry of Health andWelfare

Moderators: Ik-Kyung Jang Seung-Jung Park

10:30 AM Pathogenesis andPathologic Features ofVulnerable PlaqueErling Falk

10:50 AM MR Characterization ofAtherosclerosisChun Yuan

11:10 AM One Year Follow-Up ofPlaque RuptureMyeong-Ki Hong

11:30 AM Thermography,Spectroscopy, and OtherNew ModalitiesChristodoulos I.Stefanadis

11:50 AM IVUS, Virtual Histology,Other Ultrasound BasedImaging DiagnosticsGary S. Mintz

12:10 PM OCT/OFDIIk-Kyung Jang

12:30 PM Systemic Therapy:Pharmacologic Approachor Cell/Gene TherapyAlan C. Yeung

12:50 PM Panel Discussion

1:00 PM Adjourn

12:18 PM Complex PCIAzhar Mahmud Kiani

12:30 PM Adjourn

MAIN ARENA BVista Hall 2&3, Level B2,8:30 AM~1:30 PM

Drug Eluting Stent Summit - IV

Moderators: Eberhard GrubeAlfredo Rodriguez

8:30 AM The Xtent DES System:The Single Solution forMultilesion, Multivessel,and Long LesionTreatmentEberhard Grube

8:45 AM ZOMAXX Coronary DESTrials Update William A. Gray

9:00 AM The Infinnium Polymer-Based Paclitaxel Drug-Eluting Stent: Results Fromthe “Real World”: SIMPLE 1 and 2 RegistriesD.S. Gambhir

9:15 AM Jupiter I Beta and Jupiter IIMeta-AnalysisThierry Lefèvre

9:30 AM MEDISTRA “Excel” Drug Eluting Stent Trial(MEDISTRA): Medium-To-Long TermOutcome Teguh Santoso

9:45 AM BEACON Registry: An All-Comers Trial ofBiolimus A9 Eluting Stent Tien-Hai Koh

10:00 AM Multivessel and MultilesionStenting in Drug ElutingEra: Results from ERACI IIITrial Alfredo Rodriguez

10:15 AM Experience with SorinDrug Eluting StentJacques J. Koolen

Breakfast Meetings

Meet the Experts:Mini-Lectures and CaseDiscussions7:00 AM~8:10 AM

#7. Complex Lesion Intervention- Atheroablation,Thrombectomy, and DistalProtection

Room 2-2

Moderators: Mikihiro KijimaSamin Sharma

7:00 AM PERFECT Registry:Japanese DCA-CypherRegistry Etsuo Tsuchikane

7:10 AM The Role of DirectionalCoronary Athelectomy inthe Drug-Eluting EraMikihiro Kijima

7:20 AM Update in ThrombectomyDevicesSamin Sharma

7:30 AM The Efficacy of DES andDebulking, Role of IVUS inthe DES Era and also Datafrom Toyohashi HeartCenterTetsuo Matsubara

Case Presentations7:40 AM Supporting Guide or

Supporting Wire?Duc Huy Dinh

7:50 AM A Hard-To-Dilate Vessel inA 29-Years ManUndergoing Direct PCITak-Sun TSE

8:00 AM Modified Amplatz LeftGuiding Catheter AllowsDirect Coronary Stenting ofAnomalous Right CoronaryArtery Originating from theLeft Aortic SinusRadka Duchonova

22 l 23 Program

Program_Friday, April 28

#8. Noninvasive Imaging IsChanging the DiagnosticParadigm for CAD: IVUS, CT,FFR


Moderators: Myeong-Ki HongErick Schampaert

7:00 AM VH-IVUS: PathologicalValidationD. Geoffrey Vince

7:10 AM Cardiac CTKui-Hian Sim

7:20 AM Fractional Flow ReserveGuided Jailed Side BranchIntervention in BifurcationLesions Bon-Kwon Koo

7:30 AM FFR- and IVUS- Guided DES PCI Erick Schampaert

Case Presentations7:40 AM Multiple Fractures of

Overlapped Cypher Stentswithout RestenosisTae-Hyun Yang

7:50 AM Identification and PCI ofCulprit Lesion(s) in aMultivessel CoronaryDiseased and CardiogenicShock PatientGuy J. Friedrich

8:00 AM Confirmation of Guidewirein True Lumen by the IVUSDong Yeub Lee

#9. Chronic Total Occlusions Room 3-1

Moderators: Osamu KatohNicolaus J. Reifart

7:00 AM Chronic Total Occlusions:IVUS Guided CTO, HeartCT Guided CTO-PCI Satoru Sumitsuji

7:10 AM Current Strategies forRecanalizing Aged CTOsOsamu Katoh

7:20 AM Long-Term (Angiographic)Results of Cypher Stents inCTOs: 1 Year Follow-UpStudy of SECCTO Hweung-Kon Hwang

7:30 AM The CORACTO MulticenterRandomized DES-Trial inChronic Total OcclusionsNicolaus J. Reifart

Case Presentations7:40 AM PCI in a Thrombus

Containing LesionAfzalur Rahman

7:50 AM New CTO-PCI Strategy;Retrograde Wiring withExtended Wire TechniqueMasaaki Okutsu

#10. Structural Heart Disease -Congenital ValvularDisease, PFO, ASD, andPerivalvular Leaks

Room 2-1

Moderators: Seong-Ho Kim Robert J. Sommer

7:00 AM Aortic Valvuloplasty Ian M. Penn

7:10 AM Percutaneous ValvularIntervention Raoul Bonan

7:20 AM Patent Foramen Ovale-Smoke and MigraineRelationshipsRobert J. Sommer

Case Presentations7:30 AM Device Closure of

Acquired VSD FollowingMyocardial InfarctionPramod Jaiswal

7:40 AM Recurrent CoronaryArterio-Venous FistulaAssociated with In-StentRestenosis of Graft StentSang Yup Lim

7:50 AM Septal Myocardial Ablationby Covered Stent in aCase of ObstructiveHypertrophicCardiomyopathy Roberto Baglini

#11. Drug Eluting Stent Summit IIIRoom 4-1

Moderators: Myung-Ho JeongBernhard Meier

7:00 AM CYPHER vs. TAXUSOverview Bernhard Meier

7:10 AM New Drug Eluting StentsTo Prevent StentThrombosis andRestenosisMyung-Ho Jeong

7:20 AM Evaluation of Sirolimus-Eluting Stents Implanted inBifurcated Lesions Keiichi Igarashi

7:30 AM BioMatrix DES- My Experience in theReal WorldDamras Tresukosol

Case Presentations7:40 AM Left Main Coronary Artery

Stenting in Patient withTakayasu’s ArteritisJune Namgung

7:50 AM Do Not DiscontinueClopidogrel PrematurelyAfter Coronary StentingJ.W. van Werkum

8:00 AM To Be AnnouncedFang Chen

THE 9TH ANNUALCONFERENCE FORCARDIOVASCULAR NURSE &TECHNOLOGISTorganized by Cardiovascular TechnologyAssociation

Main Arena A, Level B2,12:30 PM~3:30 PM

12:30 PM Opening Remark Jae Yoon Ko Chairperson of CTA

12:35 PM Welcome Address Seung-Jung Park Course Director of AngioplastySummit-TCT Asia Pacific

Featured Lectures

12:40 PM Drug-Eluting Stents: From Design to Evidence-Based Medicine Seung-Jung Park

1:00 PM The Basic Interpretationand Practical Applicationsof IVUS in the Cath Lab Gary S. Mintz

Invited Lectures

1:20 PM Analyze the Relationbetween Patient'sCompliance and SocialSupport afterPercutaneous CoronaryIntervention Yan Liu

1:35 PM PCI for Chronic TotalOcclusions - VariousTechniques toBreakthrough SuchComplex Lesions Tsuyoshi Inada

1:50 PM Cath Lab HemodialysisDuring PCI for Poor RenalFunction Toshikazu Yamaguchi

Case Review Sessions

#1. Complex Lesion CasePresentations

Moderator: Jae Yoon Ko

Panelists: Seung-Nyeon KimIn-Soo KimSe-Dong ParkMi-Sook An

2:05 PM A Bifurcation Case withIVUS and OCT Guidance Hao Wang

2:15 PM PCI with Radial Approachin Bifurcation LesionDong-Chae Jung

2:25 PM PCI in Backing-Up withPercutaneous Cardio-Pulmonary Bypass SupportSystemMi-Sook An


#2. Complex Lesion CasePresentations

Moderator: Jae Yoon Ko

Panelists: Dong-Sik KimHyeon-Soo LeeJoon-Seok ChoiJin-Hyuk Park

2:45 PM Acute Cadiac Arrest DuringAngiogramSeong-Hoon Jeon

2:55 PM Graft Stent Insertion inCoronary Perforation Jung-Hoon Kim


3:15 PM Adjourn

24 l 25 Program

Learning Center_Location W-Hotel, Level B3, Lobby

Running Hours #1. Wednesday, April 26, 9:00 AM-6:00 PM#2. Thursday, April 27, 9:00 AM-6:00 PM #3. Friday, April 28, 9:00 AM-12:30 PM

IVUS Learning Center*Access to IVUS with Basic Guide - Followed Q & A with ExpertsThis pavilion allows users to select the tools related to IVUS system and provides an opportunity to learn how to interpret andmeasure diameters, areas, volumes, and image attributes. The Mentors, namely, Angioplasty Summit2006- TCT Asia Pacificfaculty lead basic guide to IVUS with Q&A, which will include a variety of excellent feedbacks with a view of expert.

Co-sponsored by Johnson & Johnson Medical Korea, Mentice and CVRF

Co-sponsored by Boston Scientific Korea, BT+, and CVRF

April 26 10:00 AM - 10:30 AMSatoru Sumitsuji, MDAdditional Findings from IVUS Compare with CINE

1:00 PM - 1:30 PMGary S. Mintz, MDHow to Utilize and Practice TeachIVUS

April 27 10:00 AM - 10:30 AMTakehiro Yamashita, MDMy Interesting Case Review with IVUS Image

1:00 PM - 1:30 PMMyeong-Ki Hong, MDIVUS Image Interpretation Tips and Technique

April 28 10:00 AM - 10:30 AMAlan C. Yeung, MDHow to Utilize IVUS: When and Why It Needs

First Venture

April 26 9:00 AM-10:00 AMSession: CoronaryMentor: Young-Keun Ahn, MD

10:15 AM-11:15 AMSession: PeripheralMentor: Young Guk Ko, MD

1:30 PM-2:30 PMSession: CoronaryMentor: Kyoo-Rok Han, MD

2:45 PM-3:45 PMSession: CoronaryMentor: Chong-Jin Kim, MD

April 27 9:00 AM-10:00 AMSession: CoronaryMentor: Junghan Yoon, MD

10:15 AM-11:15 AMSession: PeripheralMentor: Dong Hoon Choi, MD

1:30 PM-2:30 PMSession: CoronaryMentor: Hun Sik Park, MD

2:45 PM-3:45 PMSession: CoronaryMentor: Bon-Kwon Koo, MD

April 28 9:00 AM-10:00 AMSession: CoronaryMentor: Hyeon-Cheol Gwon, MD

10:15 AM-11:15 AMSession: CoronaryMentor: Taehoon Ahn, MD

Interventional Vascular Simulation Center*Hands-On Traning with Experts' NavigationInterventional Vascular Simulation offers attendees to virtually practice and procedure through hands-onexperience coronary and peripheral angioplasties. By using simulators, it allows attendees to improve theirlevel of practical and theoretical knowledge based upon the realistic tools on models. The sessionsare supported with leading physicians in this field and industry partners.

Seoul, April 25-27, 2007

Venue_The Convention Center of Sheraton Grande Walkerhill Hotel, Seoul, Korea

“Please block the dates on your calendar…”

www.summitMD.com / www.CVRF.org

2007

Oral Abstract Presentations_Wednesday, April 26, 2006 12:40 ~ 1:40 PMTutorial Auditorium A, Level 1 (Abstract nos. 1-5)

ACUTE MYOCARDIALINFARCTION

AS-1. Randomized Trial of Sirolimus-versus Paclitaxel-Eluting Stents for theTreatment of Acute ST-ElevationMyocardial Infarction

J.H. Lee1, H.S. Kim2, S.W. Lee3, J.H. Park1, S.W. Choi1, J.O. Jeong1, J.K. Chae2, J.K. Ko2,I.W. Seong1

1Chungnam National University Hospital,Daejeon, South Korea; 2Chonbuk NationalUniversity Hospital, Jeonju, South Korea;3Sooncheonyang University Hospital,Bucheon, South Korea

CARDIOMYOPATHY

AS-2. Prediction of Outcome afterPercutaneous Transluminal SeptalMyocardial Ablation for HypertrophicCardiomyopathy with Clinical,Echocardiographic, and ProceduralCharacteristics

J.M. Ten Berg2, C.V. Lee1, M.L. Geleijnse1, H.H. Idzerda2, R.V. Domburg1, W.B. Vletter1,P.W. Serruys1, F.T. Cate1

1Department of Cardiology, Thoraxcenter,Erasmus Medical Center, Rotterdam, TheNetherlands; 2Department of Cardiology, SintAntonius Hospital, Nieuwegein, TheNetherlands

DRUG ELUTING STENT

AS-3. Plaque Modification before TaxusStent Implantation in UnfavorableLesions: Results of the ROtablatorand/or Cutting Balloon to ImproveCOmpliance, (ROCCO) Study

E. Garcia, F. Sarnago, M. Abeytua, J. Pinto,L.G. Nielsen, T. Datino

Hospital General Universitario GregorioMarañon, Madrid, Madrid, Spain

AS-4. Six-Month Outcome of Sirolimus-Eluting Stent with Ticlopidine AntiplateletRegimen: Preliminary Analysis from theJ-Cypher Registry

Y. Nakagawa1, T. Kimura1, K. Mitsudo2, T. Morimoto1, Y. Hiasa3, T. Muramatsu4, Y. Hayashi5, S. Ohshima6, Y. Baba7, N. Shiode8,Y. Yokoi9, T. Sone10, S. Miyazaki11, M. Nobuyoshi12

1Kyoto Univ. Hospital, Kyoto, Japan; 2KurashikiCentral Hospital, Kurashiki, Japan; 3TokushimaRed Cross Hospital, Komatsujima, Japan;4Kawasaki Social Insurance Hospital, Kawasaki,Japan; 5Tsuchiya General Hospital, Hiroshima,Japan; 6Gunma Prefectural CardiovascularCenter, Maebashi, Japan; 7Saiseikai NoeHospital, Osaka, Japan; 8Matsue Red CrossHospital, Matsue, Japan; 9KishiwadaTokushukai Hospital, Kishiwada, Japan; 10OgakiMunicipal Hospital, Ogaki, Japan; 11NationalCardiovascular Center, Suita, Japan; 12KokuraMemorial Hospital, Kokura, Japan

VULNERABLE PLAQUE

AS-5. Relationship betweenPreprocedural High-Sensitivity C-Reactive Protein and Adverse CardiacEvents after Drug-Eluting StentImplantation

D.W. Park, Y.H. Kim, Y.H. Jeong, E.S. Hwang,B.K. Lee, K.H. Han, C.W. Lee, M.K. Hong, J.J. Kim, S.W. Park, S.J. Park

Asan Medical Center, Seoul, South Korea

Poster Abstract Presentations_Place: Exhibit Hall, Level B3

Date & Time: #1. Wednesday, April 26, 2:00~4:00 PM

#2. Thursday, April 27, 9:00~11:00 AM

#3. Thursday, April 27, 2:00~4:00 PM

MODERATED POSTERABSTRACT PRESENTATIONS

These presentations, moderated byworld-celebrated experts, will honor 5best abstracts during each posterabstract presentation session.

#1. Wednesday, April 26, 2:00~4:00 PM

(Abstract nos. 6, 25, 45~47)

Moderators: Ik-Kyung Jang, MD

Myung-Ho Jeong, MD

#2. Thursday, April 27, 9:00~11:00 AM

(Abstract nos. 48~50, 146, 161)

Moderators: Hyeon-Cheol Gwon, MD

Harry Suryapranata, MD

#3. Thursday, April 27, 2:00~4:00 PM

(Abstract nos. 178~180, 196~197)

Moderators: Myeong-Ki Hong, MD

Satoru Sumitsuji, MD

ACUTE MYOCARDIALINFARCTIONWednesday, April 26, 2:00~4:00 PM (Abstract nos. 6~24)

AS-6. Myocardial Reperfusion in STEMI; A High-Volume Single-Center Observation

C. Zorkun, K. Zmudka, M. Pasowicz, W. Tracz

The John Paul II Hospital, Krakow, Poland

AS-7. Relationship between BrainNatriuretic Peptide and Short-TermPrognosis in Patients with AcuteMyocardial Infarction

T.W. Sun1, L.X. Wang2, Y.Z. Zhang3

1The First Affiliated Hospital of ZhengzhouUniversity, Zhengzhou, China; 2School ofBiomedical Sciences, Charles Sturt University,Wagga , Wagga , Australia; 3Renji Hospital,Shanghai , Jiaotong, China

AS-8. The Impact of Time-to-Balloon onOutcomes in Patients UndergoingModern Primary Angioplasty for AcuteMyocardial Infarction

C.Y. Soon1, W.X. Chan2, H.C. Tan2

1Alexandra /National University Hospital,Singapore, Singapore; 2National UniversityHospital, Singapore, Singapore

AS-9. Association between CoronaryFlow Reserve, White Blood Cell Count,and Clinical Outcomes in Patients withAcute Myocardial Infarction

Z.G. Zheng, M.H. Yoon, S.J. Tahk, S.Y. Choi,B.J. Choi, S.G. Ahn, D.H. Li, J.H. Choi, H.S. Lim, S.J. Kang, J.H. Shin

Ajou University, Suwon, South Korea

AS-10. Feasibility and Safety of theTransradial Approach in AMI: Analysisfrom a Prospective Database of 1746Consecutive PatientsT. Unterseeh1, P. Garot1, T. Lefèvre2, O. Tavolaro1, P. Dumas2, M.C. Morice2, Y. Louvard2

1ICPS, Quincy, France; 2ICPS, Massy, France

AS-11. Short- and Long-Term Benefit ofSirolimus-Eluting Stents for Patients withAcute Myocardial Infarction

K. Sato, T. Matsubara, M. Terashima, E. Tsuchikane, M. Ehara, T. Suzuki, T. Itou, Y. Takeda, K. Nasu, N. Tanaka, A. Murata, H. Fujita, Y. Suzuki, A. Kodama, O. Kato, T. Suzuki

Toyohashi Heart Center, Toyohashi, Aichi,Japan

AS-12. Ischemia-Modified Albumin Is aHighly Sensitive Serum Marker ofTransient Myocardial Ischemia in VariantAngina Patients

J.H. Choi, D.K. Cho, J.O. Choi, S.H. Kim, S.C.Lee, H.C. Gwon

Samsung Medical Center, Seoul, South Korea

AS-13. Safety and Efficacy of the Proxis®

Protection Device in PrimaryAngioplasty: A Single-Center Experience

P. Chiam, T. Teo, V. Kwok, A. Wong, T.H. Koh

National Heart Centre, Singapore, Singapore

AS-14. Current Practice Variation ofTherapies: Findings from the ChineseRegistry of Acute Coronary Events

S.Z. Lu

Beijing Anzhen Hospital Affiliated CapitalUniversity of Medical Sciences, Beijing, China

AS-15. Effectiveness of the ReperfusionTherapy Using a Distal Protection DeviceGuided by Intravascular Ultrasound forAcute Myocardial Infarction

Y. Ito, T. Muramatsu, R. Tsukahara, K. Hirano,Y. Furuse, T. Orita, S. Fukunaga

Kawasaki Social Insurance Hospital, Kawasaki,Kanagawa, Japan

28 l 29 Oral Abstract Presentations / Poster Abstract Presentations

Poster Abstract Presentations_

AS-16. Clinical Trial of RecombinantHuman Erythropoietin Therapy in AcuteMyocardial Infarction

D.H. Shin, S.I. Choi, U.S. Park, J. Lee, S.M. Lee, J.H. Shin, J.W. Lee, K.S. Kim, S.K. Kim, J.H. Kim, H.K. Lim, B.H. Lee

Hanyang University Hospital, Seoul, SouthKorea

AS-17. Clinical and AngiographicCharacteristics of Acute MyocardialInfarction due to Vasospastic AnginaWithout Organic Coronary HeartDisease

D.B. Kim, K.B. Seung, S.W. Jang, S.H. Kim,C.S. Park, H.J. Park, D.L. Shin, P.J. Kim, H.O. Jung, S.H. Baek, K.B. Choi

Kangnam St. Mary's Hospital, Seoul, SouthKorea

AS-18. Effect of Nicorandil as an AdjunctCardioprotective Agent to PercutaneousCoronary Intervention in AcuteMyocardial Infarction

K.H. Kwon1, S.H. Park1, B.K. Lee2, B.O. Kim2,Y.S. Byun2, C.W. Ko2, J.H. Jung3 , S.H. Lee3,S.H. Choi3

1Ewha Womans University Mokdong Hospital,Seoul, South Korea; 2Inje University SanggyePaik Hospital, Seoul, South Korea; 3HallymUniversity Kangnam Sacred Heart Hospital,Seoul, South Korea

AS-19. Efficacy of Early Heparin Usebefore Primary Angioplasty in KoreanPatients with Acute Myocardial Infarction

S.J. Lee2, Y.S. Cho1, H.J. Chang1, K.I. Kim1, H.J. Chang1, W.Y. Chung1, T.J. Youn1, I.H. Chae1, D.J. Choi1, C.H. Kim1, B.H. Oh2, Y.B. Park2, Y.S. Choi2

1Bundang Seoul National University Hospital,Sungnam, South Korea; 2Seoul NationalUniversity Hospital, Seoul, South Korea

AS-20. Does IntracoronaryElectrocardiogram during CoronaryAngioplasty Reflect on MicrovascularIntegrity in Acute Myocardial Infarction?

H.J. Kim, J.S. Park, B.S. Shim, Y.J. Kim, D.G. Shin, G.R. Hong, H.S. Cho, J.W. Son

Yeungnam University Hospital, Dae-gu, SouthKorea

AS-21. The Feasibility of Xeno-Transplantation of Human UmbilicalCord Blood–and Adipose issue–DerivedMesenchymal Stem Cells into InfarctedRat Myocardium

Y.K. Ahn1, K.S. Kang2, Y.S. Kim1, M.H. Hong1,S.Y. Joo1, J.H. Kim1, W. Kim1, M.H. Jeong1, J.G. Cho1, J.C. Park1

1Chonnam National University Hospital,Gwangju, South Korea; 2Seoul NationalUniversity, Seoul, South Korea

AS-22. Relationship betweenLipoprotein(a) and SpontaneousReperfusion of Infarct-Related Artery inthe Early Phase of Acute MyocardialInfarction

J.W. Kim, H.S. Seo, S.Y. Suh, S.W. Rha, C.G. Park, D.J. Oh

Korea University Guro Hospital, Seoul, SouthKorea

AS-23. Primary Angioplasty for thePatients with Myocardial Infarction Dueto Left Main Coronary Artery Occlusion

A. Takahashi1, S. Nakajima1, T. Shudo1, Y. Takahashi1, H. Yaku2

1Takahashi Hospital, Kobe, Hyogo, Japan;2Kyoto Prefectural University of Medicine,Kyoto, Kyoto, Japan

AS-24. Ischemic Mitral Regurgitation inPatients after Successful PercutaneousCoronary Intervention in ST-SegmentElevation Myocardial Infarction

C. Zorkun, K. Zmudka, M. Pasowicz, W. Tracz

The John Paul II Hospital, Krakow, Poland

CARDIOMYOPATHYWednesday, April 26, 2:00~4:00 PM (Abstract nos. 25~26)

AS-25. Hypertrophic ObstructiveCardiomyopathy, a Single-CenterComparison of Surgical and NonsurgicalTherapies

B.E. Schölzel, H.H. D. Idzerda, M.W. F. van Gent, J.C. Kelder, P.J. Knaepen,H.A. Van Swieten, J.M. Ten Berg

St. Antonius Hospital, Koekoekslaan 1,Nieuwegein, The Netherlands

AS-26. Alcohol Septal Ablation for Hypertrophic ObstructiveCardiomyopathy Improves MyocardialPerformance

J. Veselka, R. Duchonova, S. Prochazkova, J. Palenickova, D. Zemanek, P. Svab, P. Hajek, M. Maly, P. Blasko, D. Tesar

University Hospital Motol, Prague, CZ, CzechRepublic

CARDIAC IMAGINGWednesday, April 26, 2:00~4:00 PM (Abstract nos. 27~37)

AS-27. 64-Slice Computed TomographyFacilitated Percutaneous CoronaryIntervention for Chronic Total Occlusion

H. Kaneda, T. Shiono, S. Tanaka, Y. Miyashita,S. Takahashi, Y. Taketani, H. Domae, H. Koga,J. Matsumi, S. Mizuno, Y. Minami, K. Sugitatsu,H.H. Ye, S. Saito

ShonanKamakura Hospital, Kamakura, Japan

AS-28. Detectability and Applicability ofMultislice Computed Tomography forPercutaneous Coronary Intervention forChronic Total Occluded Lesions

K. Yamazaki, M. Okutsu, M. Ihara, H. Nakaoka,M. Satou, S. Sumitsuji, Y. Nojima, K. Kishida, Y.Nagai

Rinku General Medical Center, Izumisano,Japan

AS-29. Quality Control in RoboticCoronary Surgery by IntraoperativeAngiography in Combination withPostoperative Multislice ComputerTomography

G.J. Friedrich, N. Bonaros, T. Schachner, G. Laufer, O. Pachinger, G. Feuchtner, J. Bonatti

Univerity Hospital Innsbruck, Innsbruck, Austria

AS-30. The Coronary Bifurcation StudyUsing the 64 Multidetector-RowComputed Tomography

T. Kawasaki, N. Koga, A. Kamura, H. Koga, T.Serikawa, S. Hida

Shin-Koga Hospital, Kurume, Japan

AS-31. Visualization of AtheroscleroticPlaque and Intimal Proliferation afterStenting Using Optical CoherenceTomography

B.X. Chen, F.U. Ma, W. Luo

Beijing Electric Power Hospital, Beijing, China

AS-32. Multidetector-Row ComputedTomography May Noninvasively Assessthe Coronary Reperfusion afterThrombolytic Therapy in Patients with STElevation Myocardial Infarction

D.I. Shin, K.B. Seung, K.Y. Chang, P.J. Kim,H.O. Jung, H.K. Jeon, S.H. Baek, W.S. Chung,S.J. Hong, K.B. Choi

The Catholic University of Korea, Seoul, SouthKorea

AS-33. Diagnostic Accuracy of CoronaryAngiography Using 64-MultisliceComputed Tomography

T. Shiono, S. Saito, Y. Miyashita, H. Kaneda, S.Takahashi, H. Domae, J. Matsumi, H. Koga, S. Mizuno

Shonan Kamakura General Hospital,Kamakura, Japan

AS-34. Strategic Changing of PlannedPCI Using Multidetector-Row ComputedTomography (MDCT)

A. Kamura, T. Kawasaki, N. Koga

Shin-Koga Hospital, Kurume, Fukuoka, Japan

AS-35. Improvement in the DiagnosticAccuracy of 64-Slice Multidetector-RowComputed Tomography Compared with 16-Slice MD-CT



AS-36. The Evaluation of Chronic In-Stent Restenosis Using 64Multidetector-Row Cardiac Tomography



AS-37. The Performance of SingleJudkins Left Catheter for TransradialCoronary Angiography: RandomizedComparison with Brachial Type Catheter

W. Cui, F. Liu, R.Q. Xie, X.H. Yang, G.Q. Gu,J.C. Lu, X.C. Yang, J. Du

The Second Hospital of Hebei MedicalUniversity, Shijiazhuang, Hebei, China

STENT THROMBOSISWednesday, April 26, 2:00~4:00 PM (Abstract nos. 38~44)

AS-38. Impact of Stent DeploymentPressure on Subacute Stent Thrombosiswith Drug-Eluting or Bare Metal Stents

M.A. Rahman, T. Haque, A. Khan, M. Ahmed,M. Amin, A.A. Majumder, H.S. Chaudhury

National Institute of Cardiovascular Diseases(NICVD), Sher-e-Bangla nagar, Dhaka,Bangladesh

AS-39. Acute and Subacute Incidenceand 6-Month Clinical Outcome of StentThrombosis after Sirolimus-Eluting StentImplantation

Y.D. Chen, X.T. Song, S.Z. Lu, X. Chen, Z.N. Jin, Z. Yuan, F. Tian


AS-40. Late Angiographic StentThrombosis and Sudden Cardiac Deathwith Drug-Eluting Stents-The Catholic University MulticenterStudy

Y.S. Choi, W.S. Chung, D.H. Lee, D.I. Shin, J.H. Kim, J.M. Cho, C.S. Park, P.J. Kim, J.M. Lee, K.Y. Jang, H.Y. Kim, K.D. Y, Y.S. O, D.S. Jeon, H.J. Youn, J.J. Kim, K.B. Seung, J.H. Kim, K.B. Choi, S.J. Hong

Catholic Medical College, Seoul, South Korea

AS-41. Incidence, Predictors, andOutcome of Stent Thrombosis afterSuccessful Drug-Eluting StentImplantation in Asians

S.J. Hwang, J.J. Sir, J.J. Kwak, Y.S. Kim, S.J. Lee, H.J. Kang, Y.S. Cho, B.K. Koo, T.J. Yeon, W.Y. Chung, I.H. Chae, D.J. Choi,H.S. Kim, D.W. Sohn, B.H. Oh, Y.B. Park, Y.S. Choi

Seoul National University Hospital, Seoul, SouthKorea

AS-42. Predictors of Stent Thrombosisafter Drug-Eluting Stent Implantationduring Long-Term Follow-Up

S.W. Park, D.W. Park, Y.H. Jeong,E.S. Hwang, S.H. Lee, B.K. Lee, Y.H. Kim, C.W. Lee, M.K. Hong, J.J. Kim, S.J. Park


AS-43. Impact of Triple vs DualAntiplatelet Therapy on Early ClinicalOutcomes after Drug-Eluting StentImplantation

S.W. Park, D.W. Park, Y.H. Jeong, E.S. Hwang,S.W. Lee, Y.H. Kim, B.K. Lee, C.W. Lee, M.K. Hong, J.J. Kim, S.J. Park


AS-44. Complex Lesion Type IsAssociated with Stent Thrombosis afterTaxus Stent Implantation

I.S. Kim, M.H. Jeong, W. Kim, J.H. Kim, J.G. Cho, Y.J. Hong, J.C. Park, J.C. Kang

Chonnam National University Hospital,Gwangju, South Korea

DRUG ELUTING STENTWednesday, April 26, 2:00~4:00 PM (Abstract nos. 45~47, 51~90)

Thursday, April 27, 9:00~11:00 AM (Abstract nos. 48~50, 91~130)

AS-45. Late Angiographic StentThrombosis (LAST) after Bare-MetalStent versus Drug-Eluting StentImplantation

I.W. Suh, S.W. Park, Y.H. Jeoung, E.S. Hwang,S.W. Lee, Y.H. Kim, B.K. Lee, C.W. Lee, M.K.Hong, J.J. Kim, S.J. Park

Asan Medical Center , Seoul, South Korea

AS-46. Medium- to Long-Term Outcomeof Drug-Eluting Stents in Small VesselCoronary Artery Disease: What Is theImpact of Lesion Length?

T. Santoso

University of Indonesia Medical School andMedistra Hospital, Jakarta, Indonesia

30 l 31 Poster Abstract Presentations

AS-47. Predictors of Death afterUnprotected Left Main Stenting: Insightsfrom the Left Main TAXUS Registry

T. Lefèvre1, V. Decalf1, M. Silvestri2, O. Darremont3, Y. Louvard1, J.L. Leymarie3, P. Garot4, T. Unterseeh4, P. Dumas1, O. Tavolaro4, M.C. Morice1

1ICPS, Massy, France; 2UCV, Marseille, France;3Clinique Saint Augustin, Bordeaux, France;4ICPS, Quincy, France

AS-48. Elevated Troponin-I after Drug-Eluting Stent Implantation: Incidence,Predictors, and Prognostic Value

S.W. Jang, K.B. Seung, P.J. Kim, S.H. Kim, C.S. Park, H.J. Park, D.B. Kim, H.O. Jung, S.H.Baek, K.B. Choi

KangNam St. Mary's Hospital, Seoul, SouthKorea

AS-49. Efficacy of Treatment of CoronaryIn-Stent Restenosis Using Paclitaxel-Eluting Stent

I.V. Pershukov1, T.A. Batyraliev2, B. Dokumaci2,I.V. Levitsky3, A.V. Sozykin3, S.T. Jamgyrchiev3,Z.A. Karben2, A.N. Samko3, I.A. Lazarev1, Y.V. Pya2, Y.N. Belenkov3

1Regional Clinical Hospital, Voronezh, RussianFederation; 2Sani Konukoglu Medical Center,Gaziantep, Turkey; 3Cardiology ResearchCenter, Moscow, Russian Federation

AS-50. One-Year Outcome followingSirolimus-Eluting Stent Implantation inCoronary Bifurcation Lesions

L. Ge1, I. Iakovou2, J. Cosgrave2, A. Colombo2,J. Ge1

1Zhongshan Hospital, Fudan University,Shanghai, China; 2EMO Centro CuoreColumbus and San Raffaele Hospital, Milan,Italy

AS-51. Characteristics and Outcomesafter Implantation of Single versusMultiple Biolimus A9-Eluting Stents inHuman Coronary Arteries (The BEACON Registry)

D. Tresukosol

Siriraj Hospital, Bangkok, Thailand

AS-52. Paclitaxel-eluting Stent for theTreatment of Unprotected Left MainDisease: Immediate and Midterm Results

E. Garcia, F. Sarnago, J. Pinto, M. Abeytua,L.G. Nielsen, G. Bocuzzi, T. Datino

Gregorio Marañon, Madrid, Madrid, Spain

AS-53. Effect of Adjunctive Ballooningfollowing Drug-Eluting Stent Implantationon the Clinical and AngiographicOutcomes

S.J. Lee1, W.Y. Chung2, J.S. Park1, H.J. Kang1,Y.S. Cho2, B.K. Koo1, T.J. Youn2, I.H. Chae2,D.J. Choi2, H.S. Kim1, D.W. Sohn1, B.H. Oh1, Y.B. Park1, Y.S. Choi1

1Seoul National University Hospital, Seoul,South Korea; 2Bundang Seoul NationalUniversity Hospital, Sungnam, South Korea

AS-54. Six-Month Clinical andAngiographic Outcomes of Small-VesselStenting Using a 2.25-mm Paclitaxel-Eluting Stent

J.W. Kim, S.W. Rha, S.Y. Suh, C.G. Park, H.S. Seog, D.J. Oh

Cardiovascular Center, Korea University GuroHospital, Seoul, South Korea

AS-55. Efficacy of Sirolimus-ElutingStents in the Treatment of Chronicversus Nonchronic Total OcclusionLesions

H. Kaneda, S. Tanaka, Y. Miyashita, T. Shiono, S. Takahashi, Y. Taketani, H. Domae, H. Koga, J. Matsumi, S. Mizuno, Y. Minami, K. Sugitatsu, H.H. Ye, S. Saito


AS-56. Six-Month Angiographic andClinical Outcomes of Full Metal Jacketwith Drug-Eluting Stents over a DiffuseLong De Novo Coronary Lesion

J.W. Kim, S.Y. Suh, S.W. Rha, C.G. Park, H.S. Seog, D.J. Oh


AS-57. One Year Clinical andAngiographic Outcomes following Drug-Eluting Stent Implantation in Left MainBifurcation Lesions

L. Ge1, J. Cosgrave2, I. Iakovou2, A. Colombo2,J. Ge1

1Zhongshan Hospital, Fudan University,Shanghai, China; 2EMO Centro CuoreColumbus and San Raffaele Hospital, Milan,Italy

AS-58. Efficacy of Sirolimus-ElutingStents Compared with Bare Metal Stentsfor Saphenous Vein Graft Intervention

S.W. Rha1, S.Y. Suh1, J.W. Kim1, C.G. Park1, H.S. Seo1, D.J. Oh1, R. Waksman2

1Korea University Guro Hospital, Seoul, SouthKorea; 2Washington Hospital Center,Washington D.C., United States

AS-59. Safety and Midterm Outcomes ofReal-World Unprotected Left MainIntervention Regardless of LeftVentricular Dysfunction

S.W. Rha, S.Y. Suh, J.W. Kim, C.G. Park, H.S. Seo, D.J. Oh


AS-60. Acute and Midterm Clinical andAngiographic Outcomes with Sirolimusand Paclitaxel Stents

I.C. Hsieh1, H.L. Huang2, C.C. Chen1, H.J. Chang2, D. Wu1

1Chang Gung Memorial Hospital , Tao-Yuan,Taiwan; 2Tzu Chi Buddhist General Hospital,Taipei Branch, Taipei, Taiwan

AS-61. Six-Month Outcomes of RightCoronary Artery Ostial versus Non-RightCoronary Artery Ostial Intervention withDrug-Eluting Stents



AS-62. Acute and Chronic InflammatoryReactions in Response to IntracoronaryStent Implantation in Patients withAngina

H.S. Cho, J.S. Park, Y.J. Kim, D.G. Shin, G.R. Hong

Yeungnam University Hospital, Dae-gu, SouthKorea


AS-63. Additional Ballooning versus NoAdditional Ballooning after Drug-ElutingStent Implantation in Routine ClinicalPractice

S.Y. Suh, J.W. KIM, C.G. Park, H.S. Seo, D.J. Oh, S.W. Rha


AS-64. A Biodegradable Polymer-BasedSirolimus-Eluting Stent for Treatment ofSecondary Complication in Patients withCoronary Artery Disease

S.I. Dani

Sal Hospital and Medical Institute Ahmedabad,Gujarat, India

AS-65. Predictors of Target LesionRevascularization and Major AdverseClinical Events after PercutaneousCoronary Intervention with Drug-ElutingStents

J.Y. Hanh, J.S. Park, Y.S. Cho, H.J. Kang, B.K. Koo, W.Y. Chung, T.J. Youn, I.H. Chae,D.J. Choi, H.S. Kim, B.H. Oh, Y.B. Park


AS-66. Comparison of Cypher and Taxusin Chronic Total Occlusive Lesions:Korean Multicenter Angioplasty Team(COMATE) Registry

S.H. Lee1, J. Yoon1, S.K. Ryu2, J.Y. Yang3, B.O. Kim4, H.M. Kwon5, Y.S. Jang5, J.H. Jung6,S.H. Lee6, S.H. Choi6, S.H. Park7

1Eulji University Hospital, Seoul, South Korea;2NHIC Ilsan Hospital, Ilsan, Kyung Ki Do, SouthKorea; 3Inje University, Inje, South Korea;4Yonsei University, Seoul, South Korea; 5HallymUniversity, Choon Chun, South Korea; 6HallymUniversity, Choon Chun, South Korea; 7EhwaUniversity, Seoul, South Korea

AS-67. Incidence and Predictors of LateCardiac Death after Sirolimus-ElutingStent Implantation in Routine ClinicalPractice

H.J. Kim, S.J. Park, Y.J. Kim, D.G. Shin, B.S. Sim, G.R. Hong

Yeungnam University Hospital, Dea-gu, SouthKorea

AS-68. Possibilities and Limitations ofthe Cypher Stent Platform for CoronaryBifurcation Lesions

Y. Hikichi, S. Hashimoto, D. Fujimatsu, T. Morooka, N. Kotooka, F. Uchida, T. Matsushita, T. Inoue, K. Node

Saga University School of Medicine, Saga,Japan

AS-69. Predictive Factors of In-StentRestenosis after Drug-Eluting StentImplantation

H.M. Choe, J. Yoon, H.Y. Yoo, H.J. Park, J.Y. Kim, B.S. Yoo, S.H. Lee, K.H. Choe

Wonju Christian Hospital, Wonju, Kang WonDo, South Korea

AS-70. Sirolimus-Eluting Stents Rubbingagainst the Vessel Wall BeforeImplantation: MidtermOutcomes

Y. Nishibori, N. Inoue, Y. Otsuki, N. Takechi,K. Suzuki, A. Matsuo, K. Inoue, T. Tanaka, H. Fujita

Kyoto Second Red Cross Hospital, Kyoto,Japan

AS-71. Sirolimus-Eluting StentImplantation in Patients with ChronicRenal Failure (>10 Years on Dialysis):Procedural Features and 8-MonthFollow-Up

Y. Nishibori, N. Inoue, Y. Otsuki, N. Takechi, K. Suzuki, A. Matsuo, K. Inoue, T. Tanaka, H. Fujita


AS-72. Comparison of Cutting BalloonAngioplasty and Drug-Eluting Stent forFocal In-Stent Restenosis

S.R. Lee, M.H. Jeong, Y.J. Hong, J.H. Kim,W. Kim, J.G. Cho, Y.K. Ahn, J.C. Park, J.C. Kang


AS-73. Impact of Drug-Eluting Stents onthe Treatment of Native Coronary OstialLesions



AS-74. Midterm Outcomes ofImplantation of 3 or More Drug-ElutingStents in Multivessel Coronary ArteryDisease



AS-75. Sirolimus-Eluting PronovaStents—A Single-Center Experiencefrom India

S. Kumar, N. Sinha, A. Kapoor

Sanjay Gandhi Postgraduate Institute ofMedical Sciences, Lucknow, UP, India

AS-76. Novel Drug-Eluting Stent Systemwith a Polymer Free, On-Site StentCoating: Single Center Experience

N. Sinha, S. Kumar, A. Kapoor

Sanjay Gandhi Postgraduate Institute ofMedical Sciences, Lucknow, UP, India

AS-77. Direct Stenting with Sirolimus-Eluting Stent: Short- and Long-TermAngiographic and Clinical Follow-up

I. Nazeri, A. Nazeri, B.S. Kashani, K. Hashemy,P. Shahabi

Tehran Medical University, Nazeri HeartInstitute, Tehran, Iran

AS-78. Sirolimus-Eluting Stents—4 YearClinical Experience: Early and Late Angiographic and ClinicalOutcome

I. Nazeri, A. Nazeri, B.S. Kashani, K. Hashemy,P. Shahabi

Tehran Medical University, Nazeri HeartInstitute, Tehran, Iran

AS-79. Single-Center Experience with aNew Biodegradable Polymer BasedSirolimus-Eluting Stent System

S.I. Dani, J.S. Prajapati, S.R. Jain, H.R. Joshi,S.S. Thanvi, S. Ghosh, K. Sharma, J. Shah, H. Shah, A. Jain, T. Madan, M. Bansal

Deptartment of Cardiology, U.N.Mehta Instituteof Cardiology and Research Center,Ahmedabad, Gujarat, India


AS-80. Taxus Kissing Stenting inBifurcation Lesions: Multicenter Registry

H.C. Gwon1, Y.S. Jang2, T.H. Ahn3, M.K. Hong4

1Sungkyunkwan University, Seoul, South Korea;2Yonsei University, Seoul, South Korea;3Gachon Medical School, Inchon, South Korea;4Ulsan University, Seoul, South Korea

AS-81. Do Cobalt Chrome Stents and Paclitaxel-Eluting Stents HaveEquivalent Clinical Results inNoncomplex Lesion? The COPE Study

H.C. Gwon1, T.H. Ahn2, S.H. Hur3, I.H. Chae4, D.I. Kim5, K.R. Han6, H.S. Park7, D.S. Lim8, K.J. Lee9, S.Y. Lee10, K.J. Ahn11

1Samsung Medical Center, Seoul, South Korea;2Inchon Ghil Hospital, Inchon, South Korea;3Kyemyung University, Dae-gu, South Korea;4Bundang Seoul National University Hospital,Sungnam, South Korea; 5Busan Baek Hospital,Busan, South Korea; 6Kangdong SacredHospital, Seoul, South Korea; 7KyungbukUniversity, Dae-gu, South Korea; 8KoreaUniversity, Seoul, South Korea; 9Daejeon EuljiHospital, Daejeon, South Korea; 10Ilsan BaekHospital, Ilsan, South Korea; 11Hanil Hospital,Seoul, South Korea

AS-82. Predictive Factors for Long-TermRestenosis with Cypher Stents

S. Fukunaga, T. Muramatsu, R. Tsukahara, Y. Ito, K. Hirano, Y. Furuse, T. Orita

Kawasaki Social Insurance Hospital, Kanagawa, Japan

AS-83. Elective Sirolimus-Eluting StentImplantation for Unprotected Left MainCoronary Artery Disease

I.V. Pershukov1, I.A. Lazarev2, T.A. Batyraliev3,A.N. Samko4, I.V. Levitsky4, Y.V. Pya3, Z.A. Karben3, A.V. Sozykin4, O. Dogru4, A. Sercelik3, B. Dokumaci3

1Regional Clinical Hospital, Voronezh, RussianFederation; 2Presidential Medical Center,Moscow, Russian Federation; 3Sani KonukogluMedical Center, Gaziantep, Turkey; 4CardiologyResearch Center, Moscow, Russian Federation

AS-84. Clinical, Angiographic, andProcedural Predictors of AngiographicRestenosis after Sirolimus-Eluting StentImplantation in Complex CoronaryLesions in the Real World

Y.D. Chen, X.T. Song, X.Z. Lu, X. Chen, Z.N. Jin, F. Yuan, F. Tian

Capital University of Medical Sciences AffiliatedBeijing Anzhen Hospital, Beijing, China

AS-85. Do Drug-Eluting Stents ReallyImprove Clinical Outcomes ofPercutaneous Coronary Intervention inDaily Practice?

J.H. Choi, H.C. Gwon, S.H. Lee, K.P. Hong, J.E. Park


AS-86. Single-Center Comparison ofSirolimus and Paclitaxel-Eluting Stents inClinical Practice

J.H. Choi, H.C. Gwon, S.H. Lee, K.P. Hong, J.E. Park


AS-87. Comparison of Sirolimus- andPaclitaxel-Eluting Stents in Clinical andAngiographic Outcomes in KoreanCoronary Artery Disease Patients—theKorean COronary MulticenterAngioplasty TEam (COMATE) Registry

C.Y. Shim1, Y.G. Ko1, D. Choi1, Y. Jang1,W.H. Shim1, S.Y. Cho1, H.M. Kwon2, J.H. Yoon3, S.H. Park4, B.O. Kim5, J.Y. Yang6,S.H. Choi7

1Severance Cardiovascular Center, Seoul,South Korea; 2Yongdong Severance Hospital,Seoul, South Korea; 3Wonju Christian Hospital,Seoul, South Korea; 4Ehwa Womans UniversityMokdong Hospital, Seoul, South Korea; 5InjeUniversity Sanggye P. Hospital, Seoul, SouthKorea; 6Ilsan Hospital, Go-Yang , Kyung-Ki Do,South Korea; 7Hallym University Kangnam S.Hospital, Seoul, South Korea

AS-88. Abciximab-Coated Stents InhibitVascular Inflammatory ReactionEffectively in a Porcine Coronary Model

Y.J. Hong, M.H. Jeong, J.H. Kim, S.R. Lee, S.Y. Lim, W. Kim, Y.K. Ahn, J.G. Cho, J.C. Park


AS-89. Catheter-Induced Left MainCoronary Artery Dissection andEmergency Percutaneous CoronaryIntervention with Drug-Eluting Stents:Acute and Midterm Results

J. Balcells, T. Lefevre, Y. Louvard, P. Dumas, A. Rosas, V. Decalf, M.C. Morice

ICPS, Massy, France

AS-90. Passive Cigarette Smoke Has anAcute Adverse Effect on Arterial Stiffnessin Nonsmokers

Y.S. Lee, C.W. Park, C.W. Nam, S.W. Han, S.H. Hur, K.S. Kim, Y.N. Kim, K.B. Kim

Dongsan Medical Center, Keimyung University,Dae-gu, South Korea

AS-91. Long-Term Results of Sirolimus-Eluting Stents in Acute MyocardialInfarction

Y.S. Lee, K.B. Kim, C.W. Nam, S.W. Han, S.H. Hur, K.S. Kim, Y.N. Kim

Dongsan Medical Center, Keimyung University,Dae-gu, South Korea

AS-92. Initial and Long-term Outcome ofElective Percutaneous CoronaryIntervention for Unprotected Left MainCoronary Artery Stenosis in the Drug-Eluting Stent Era

H. Araki, M. Ochiai, N. Ogata, C. Obara, K. Ashida, N. Isomura

Showa University Northern Yokohama Hospital,Yokohama, Japan

AS-93. Comparison of Restenosis Ratesbetween Cobalt-Chronium Thin-StrutStents and Sirolimus-Eluting Stents inRelatively Simple Lesions: The Korean Multicenter AngioplastyTeam (COMATE) Registry

B.K. Kim1, Y.G. Ko2, S. Oh1, D.W. Jeon1, D. Choi2, Y. Jang2, J.Y. Yang1

1NHIC Ilsan hospital, Koyang-shi, Kyonggi-do,South Korea; 2Yonsei University SeveranceHospital, Seoul, South Korea

AS-94. Comparison of Short and Long-Term Outcomes between Cypher andTaxus Stents in Patients with ComplexLesions

J. Chen, R. Gao, Y. Yang, S. Qiao, X. Qin, M. Yao, B. Xu

Cardiovascular Institute and Fu Wai Hospital,Chinese Academy of Medical Science andPeking Union Medical College, Beijing, China

AS-95. Clinical Outcomes of 2 Drug-Eluting Stents for Bifurcation Lesions

J. Chen, R. Gao, Y. Yang

Cardiovascular Institute and Fu Wai Hospital,Chinese Academy of Medical Sciences andPeking Union Medical College, Beijing , China


AS-96. A Novel Biodegradable andBiocompatible Polymeric Stent Coating

X.B. Liu1, J.B. Ge1, S.J. Cheng2, Y.C. Zhao2, J.Y. Qian1, K.Q. Wang1

1Zhongshan Hospital, Shanghai, China;2Institute of Materials Science, East ChinaUniversity of Science and Technology,Shanghai, China

AS-97. Long-Term Study of NovelBiodegradable Polymeric ArsenicTrioxide(As2O3)-Eluting Stent Implantingin the Porcine Coronary Model

J.B. Ge1, X.B. Liu1, Y. Wei1, J.Y. Qian1, K.Q. Wang1, X.F. Wang1, J.G. Jiang1, R.M. Yao1,S.J. Cheng2, Y.C. Zhao2

1Zhongshan Hospital, Shanghai, China;2Institute of Materials Science, East ChinaUniversity of Science and Technology,Shanghai, China

AS-98. Left Main Stenting for OstialLesions of the Left Anterior Descendingand Circumflex Arteries: Results from the Taxus Pilot Study

T. Lefèvre1, P. Pillay1, O. Darremont2, M. Silvestri3, M.C. Morice1, Y. Louvard1, J.L. Leymarie2, P. Garot4, T. Unterseeh4, P. Dumas1

1ICPS, Massy, France; 2Clinique Saint Augustin,Bordeaux, France; 3UCV, Marseille, France;4ICPS, Quincy, France

AS-99. The Risk of Subacute Thrombosisafter Drug-Eluting Stenting in the RealWorld

I.V. Pershukov1, T.A. Batyraliev2, N. Guler3, B. Dokumaci2, I.V. Levitsky4, A.N. Samko4, Z.A. Karben2, F. Besnili2

1Regional Clinical Hospital, Voronezh, RussianFederation; 2Sani Konukoglu Medical Center,Gaziantep, Turkey; 3Yuzuncu Yil Univesity, Van,Turkey; 4Cardiology Research Center, Moscow,Russian Federation

AS-100. Impact of Drug-Eluting StentImplantation for Treatment of Left MainCoronary Artery Disease: Comparisonwith Bypass Surgery and Bare MetalStents

N. Tanaka, M. Ehara, A. Kodama, Y. Suzuki, K. Sato, H. Fujita, A. Murata, J.F. Surmely, K. Nasu, Y. Takeda, I. Ito, T. Suzuki, Y. Kinoshita, E. Tsuchikane, M. Terashima, T. Matsubara, O. Kato, T. Suzuki


AS-101. Fluoroscopic and EndoscopicObservations of Crush and Kissing StentTechniques in a 3-Dimensional Left MainBifurcation Phantom Model

Y. Murasato, Y. Nagai, K. Okamatsu

Chikuho Social Insurance Hospital, Nogata,Japan

AS-102. Drug-Eluting Stents for ElectiveTreatment of Left Main Lesions: Are theResults Different in Patients Aged >75Years?

P. Garot1, T. Lefèvre2, Y. Louvard2, M. Silvestri3,O. Darremont4, P. Dumas2, M.C. Morice1

1ICPS, Quincy, France; 2ICPS, Massy, France;3UCV, Marseille, France; 4Clinique Saint-Augustin, Bordeaux, France

AS-103. Use of Excel, a New Sirolimus-Eluting Stent, in Real-World Cases(MEDISTRA: Medistra Excel Drug-elutIngSTent TRiAl)

T. Santoso1, A. Wong2, T.H. Koh2

1University of Indonesia Medical School andMedistra Hospital, Jakarta, Indonesia; 2NationalHeart Centre, Singapore, Singapore

AS-104. Emodin Inhibits the Migrationand Proliferation of Vascular SmoothMuscle Cells Independent of Metabolism

X.F. Wang, A.J. Sun, D.L. Xu, K.Q. Wang, J.B. Ge

Zhongshan Hospital, Shanghai, China

AS-105. Do We Need Larger Drug-Eluting Stents?

C.W. Nam

Keimyung university, Daegu, Korea, SouthKorea

AS-106. Drug-Eluting Stents for ElectiveTreatment of Left Main Lesions: Are theResults Different in High-Risk Patientsfor Cardiac Surgery? A Report from aMulticenter Registry



AS-107. Left Main Taxus Pilot Study.Midterm Follow-Up

T. Lefèvre1, O. Darremont2, M.C. Morice1, M. Silvestri3, Y. Louvard1, P. Garot4, J.L. Leymarie2, J. Balcells1, P. Dumas1

1ICPS, Massy, France; 2Clinique Saint-Augustin,Bordeaux, France; 3UCV, Marseille, France;4ICPS, Quincy, France

AS-108. Are the Results of Drug-ElutingStents for the Elective Treatment ofUnprotected Left Main Lesions Differentin Patients with Diabetes?



AS-109. Safety of Incompletely ApposedDrug-Eluting Stent Strut at Left MainCoronary Artery Protruded from ProximalLeft Anterior Descending CoronaryArtery

S.H. Jo1, T.J. Youn2, H.J. Kang1, Y.S. Cho2, W.Y. Chung2, I.H. Chae2, D.J. Choi2, H.S. Kim1,D.W. Sohn1, B.H. Oh1, Y.B. Park1, Y.S. Choi1,B.K. Koo1

1Seoul National University Hospital, Seoul,South Korea; 2Seoul National UniversityBundang Hospital, Seoul, South Korea

AS-110. Drug-Eluting Stent Implantationin Small Coronary Arteries in the RealWorld: Is It Safe?

C.W. Nam

Keimyung university, Dae-gu, Korea, SouthKorea

AS-111. Drug-Eluting Stent for Left MainBifurcation Stenosis: Better Results, butCan We Still Improve?

T. Santoso

Division of Cardiology, Department of InternalMedicine, University of Indonesia MedicalSchool Medistra Hospital, Jakarta, Indonesia

AS-112. Efficacy and Safety of Sirolimus-Eluting Stents with BioabsorbablePolylactic Acid Coating in the Treatmentof Human Coronary Arterial Diseases

J. Qian, X. Wang, B. Fan, W. Yan, Q. Wang, S. Cui, J. Ge



AS-113. Transradial Intervention for LeftMain Coronary Artery Lesions

T. Shiono, S. Saito, Y. Miyashita, S. Takahashi,H. Domae, H. Kaneda, H. Koga, J. Matsumi, S. Mizuno

Heart Center of Shonankamakura GeneralHospital, Kamakura, Japan

AS-114. The Efficacy of Sirolimus-ElutingStent Implantation for Small CoronaryArtery Compared with Bare Metal BXVelocity Stent

Y. Otsuki, N. Inoue


AS-115. Sirolimus-Eluting, BioerodablePolymer-Coated Constant Stent (Cura) inAcute ST-Elevation MyocardialInfarction-a Safety and Feasibility Study

C.H. Lee, H.C. Tan, J. Lim, A. Low, X.L. Zhang,Y.T. Lim

The Heart Institute, Singapore, Singapore

AS-116. Short-Term Outcomes of theStaged Sirolimus-Eluting StentImplantation to Small or Diffuse Lesionsin Patients with Acute

M. Kawamura, S. Suwa, S. Kojima, S. Itoh, T. Ichinose, H. Hayashi, T. Miyazaki, S. Miyazaki, H. Sakurai, M. Sumiyoshi

Juntendo University Shizuoka Hospital,Shizuoka, Japan

AS-117. Identification of Patients at LowRisk of 6-Month In-Stent Restenosis ofBare Metal Stenting in the Real World

C.B. Park, M.K. Hong, C.W. Lee, B.K. Lee, Y.H. Kim, S.W. Lee, I.W. Suh, D.H. Kang, S.S. Cheong, J.K. Song, J.J. Kim, S.W. Park,S.J. Park


AS-118. Comparison of the Efficacy ofDrug-Eluting Stents versus Bare MetalStents in the Treatment of Patients withNative Coronary Lesions and ChronicRenal Failure

Y.H. Jeong, S.W. Park, E.S. Hwang, S.W. Lee,Y.H. Kim, B.K. Lee, C.W. Lee, M.K. Hong, J.J. Kim, S.J. Park


AS-119. Comparison of Early andMidterm Outcomes after Sirolimus-Eluting Stent Implantation VersusCoronary Artery Bypass Grafting inPatients with Multivessel Coronary ArteryDisease

K.M. Park, M.K. Hong, C.W. Lee, B.K. Lee, Y.H. Kim, E.S. Hwang, S.E. Lee, D.H. Kang, S.S. Cheong, J.K. Song, J.J. Kim, S.W. Park,S.J. Park


AS-120. Comparison between Sirolimus-and Paclitaxel-Eluting Stents for theTreatment of Chronic Total Occlusions

J.S. Jang, M.K. Hong, C.W. Lee, D.W. Park,B.K. Lee, Y.H. Kim, K.H. Han, J.J. Kim, S.W. Park, S.J. Park


AS-121. Safety and Efficacy of RepeatSirolimus-Eluting Stent Implantation forIn-Stent Restenosis of Drug-ElutingStents: Comparison with ConventionalTreatment

Y.H. Kim, S.W. Park, B.K. Lee, D.W. Park, E.S. Hwang, Y.H. Jeong, S.W. Lee, C.W. Lee,M.K. Hong, J.J. Kim

Asan Medical Center, Seoul, Seoul, SouthKorea

AS-122. Linear Membrane Formationafter Kissing Stent Placement withSirolimus-Eluting Stents: Incidence andCorrelation with Long-Term Outcomes

E.S. Hwang, Y.H. Kim, M.K. Hong, C.W. Lee,K.H. Park, D.W. Park, Y.H. Jeong, S.W. Lee,J.J. Kim, S.W. Park

Asan Medical Center, Seoul, Seoul, SouthKorea

AS-123. Prediction of Adverse ClinicalOutcomes in Unprotected Left MainCoronary Artery Stenting Using RiskStratification System of EuroSCORE

S.J. Park, Y.H. Kim, J.M. Ahn, D.W. Park, Y.H. Jeong, E.S. Hwang, S.H. Lee, C.H. Lee,M.K. Hong, J.J. Kim, S.W. Park

Asan medical center, Seoul, South Korea

AS-124. Efficacy of Sirolimus-ElutingStent Implantation for In-StentRestenosis: Comparison with Cutting Angioplasty

M. Kawamura, S. Suwa, S. Itoh, H. Hayashi, T. Ichinose, S. Miyazaki, T. Miyazaki, S. Kojima, H. Sakurai, M. Sumiyoshi

Juntendo University Shizuoka Hospital,Shizuoka, Japan

AS-125. Immediate and IntermediateClinical Angiographic Follow-Up of Drug-Eluting Stents: The Prince Sultan CardiacCenter Experience

S.A. Al Kasab, M.A. Al Fagih, Y.A. Beshir, M.M. Al Anazi, H.S. Al Amri, M.A. Al Otaiby,M.M. Al Abdullah, A.A. Amro

Prince Sultan Cardiac Center, Riyadh, SaudiArabia

AS-126. Comparison of Clinical andLong-Term Angiographic Resultsbetween Paclitaxel and Sirolomus Drug-Eluting Stents with High-Risk Patients

S.A. Al Kasab, M.A. Al Fagih, Y.A. Beshir, M.M. Al Anazi, H.S. Al Amri, M.A. Al Otaiby,M.A. Al Abdullah, A.A. Amro

Prince Sultan Cardiac Center, Riyadh, SaudiArabia

AS-127. Predictors for Late StentThrombosis following Drug-Eluting StentImplantation

T.H. Ahn, K.J. Oh, W.C. Kang, S.H. Han

Gil Medical Center, Incheon, South Korea

AS-128. Is Pattern of Arterial Remodelinga Contributing Factor to NeointimalHyperplasia after Stent Implantation inthe DES Era? An IntravascularUltrasound Study

W.C. Kang, S.H. Han, K.J. Oh, T.H. Ahn, E.K. Shin

Gachon Medical School , Incheon, South Korea

AS-129. Intravascular Ultrasound Studyof Effects of Overlapping with DifferentDrug-Eluting Stents

W.C. Kang, S.H. Han, K.J. Oh, T.H. Ahn, E.K. Shin

Gachon Medical School , Incheon, South Korea


AS-130. Outcome of Patients with End-Stage Renal Failure UndergoingPercutaneous Coronary Intervention inthe Drug-Eluting Stent Era

K.L. Tsui, T.S. Tse, C.K. Chan, M.C. Choi, W.C. Ko, K.K. Chan, S.K. Li

Pamela Youde Nethersole Eastern Hospital,Chai Wan, Hong Kong, Hong Kong SpecialAdministrative Region of China

BALLON ANGIOPLASTYThursday, April 27, 9:00~11:00 AM(Abstract nos. 131~132)

AS-131. Preoperative Depression and 1-Year Prognosis in Patients afterPercutaneous Coronary Intervention

S.U. Bianling, L.I. Yongjun, Y. Rong, Z.H. Hui,L.I. Suyun, Z.U. Xiuguang

Second Hospital,Hebei Medical University,Shijiazhuang, Hebei, China

AS-132. Long-Term Follow-Up ofEndovascular Treatment for AorticDissection

B. Hao, Z.Q. Pang, J.S. Gao, X.M. Zheng

Affiliated Kailuan Hospital, Tangshan, Hebei,China

CONGENITAL HEART DISEASEThursday, April 27, 9:00~11:00 AM(Abstract nos. 133~136)

AS-133. Transcatheter Occlusion ofPatent Ductus Arteriosus with SeverePulmonary Hypertension

F. Zhang, J. Ge, D. Zhou, L. Guan

Zhongshan Hospital, Fudan University,Shanghai , China

AS-134. Rotational DigitalAngiocardiography in Congenital HeartDisease: Single Center Experience

S.S. Thanvi, S.I. Dani, J.S. Prajapati, S.R. Jain,H.R. Joshi, S. Ghosh, K. Sharma, J. Shah, H. Shah, A. Jain, T. Madan, M. Bansal

U.N.Mehta Institute of Cardiology andResearch Centre, Ahmedabad, Gujarat, India

AS-135. Transcatheter Closure of VeryLarge Patent Ductus Arteriosus with theModified Patent Ductus ArteriosusClosure Device


Zhongshan Hospital, Fudan University,Shanghai, China

AS-136. Transcatheter Occlusion ofComplex Patent Ductus Arteriosus


Zhongshan Hospital, Fudan University,Shanghai, China

CORONARY THROMBUSThursday, April 27, 9:00~11:00 AM(Abstract nos. 137)

AS-137. Incidence, Predictors, andOutcomes of Device Failure of X-SizerThrombectomy: Real-World Experience of 200 Cases in 5 Years

C.H. Lee1, X.L. Zhang1, H.C. Tan1, H.B. Wong2,S. Fun1, M. Gay1, L. Qu1, J. Lim1, A. Low1, Y.T. Lim1

1National University Hospital, Singapore,Singapore; 2Clinical Trials and EpidemiologyResearch Unit, Singapore, Singapore

DISTAL EMBOLIC PROTECTIONThursday, April 27, 9:00~11:00 AM(Abstract nos. 138~140)

AS-138. Does Thrombectomy with the X-Sizer Catheter System ImproveMyocardial Perfusion in Patients with ST-Segment Elevation MyocardialInfarction?

E. Garcia, T. Datino, J. Pinto, M. Abeytua,F. Sarnago

Hospital General Universitario GregorioMarañón, Madrid, Madrid, Spain

AS-139. Impact of Attenuated Plaquewithout Obvious Calcifications on Slow-Flow or No-Flow Phenomenon duringElective Percutaneous CoronaryIntervention

H. Yamaguchi, S. Toyoshima, Y. Toyama

Nanpuh Hospital, Kagoshima, Kagoshima,Japan

AS-140. Do We Need Distal ProtectionDevices in Carotid Artery Stenting?

S.H. Han, W.C. Kang, K.J. Oh, T.H. Ahn, E.K. Shin

Gil Hospital, Gachon Medical School , Incheon,South Korea

GENETIC OR MOLECULARCARDIOLOGYThursday, April 27, 9:00~11:00 AM(Abstract nos. 141~145)

AS-141. The Effect of GranulocyteColony–Stimulating Factor on LeftVentricular Function and In-StentRestenosis in the Porcine MyocardialInfarction Model

S.Y. Lim, M.H. Jeong, Y.K. Ahn, Y.J. Hong, Y.S. Kim, J.H. Kim, W. Kim, J.G. Cho, J.C. Park,J.C. Kang


AS-142. Is There Additional Benefit ofIntracoronary Transplantation ofAutologous Peripheral Blood Stem Cellsin Patients with Acute MyocardialInfarction?

J.H. Choi, J.O. Choi, W.S. Lee, S.C. Lee, H.C. Gwon, E.S. Jeon, D.K. Kim, S.H. Lee


AS-143. Polymorphism of the Receptorfor Advanced Glycation End Products(RAGE) Gene Is Associated with Risk ofCoronary Artery Disease

S.J. Yoon1, S.H. Park1, C.M. Park1, Y.G. Ko1,D.H. Choi1, H.Y. Park2, Y.S. Jang1, N.S. Chung1

1Yonsei Medical Center , Seoul , South Korea;2National Institute of Health, Seoul , SouthKorea


AS-144. Inhibitive Effect of ConstantMagnetic Fields on Secretion andExpression of Monocyte ChemoattractantProtein–1 and Vascular Cell AdhesionMolecule–1 in Human Vascular SmoothMuscle Cells

H.X. Cheng, H.C. Wang, W.Y. Guo, G.L. Gia

Xijing Hospital, Xi’an, Shanxi, China

AS-145. Remote PreconditioningInduced by Skeletal Muscle IschemiaReducing Matrix MetalloproteinaseExpression in Porcine Myocardium

R.Q. Xie, W. Cui, F. Liu, Y.M. Hao, J. Du, B.H. Li

Hebei Medical University the Second Hospital,Shijiazhuang, Hebei, China

PHARMACOLOGI-CALTREATMENTThursday, April 27, 9:00~11:00 AM(Abstract nos. 146~160)

AS-146. The Effect of Cilostazol onRestenosis after Coronary Bare MetalStent Implantation

Y.D. Chen, S.Z. Lu, Y.L. Lu, Z.N. Jin, H. Li, W.Q. Pan

Beijing Anzhen Hospital, Capital University ofMedical Sciences, Beijing, China

AS-147. Celecoxib Is Safe and ReducesPeriprocedural Inflammation afterPercutaneous Coronary Intervention

Y.S. Kim1, J.Y. Hahn1, S.H. Jo1, H.M. Yang1, H.S. Min1, B.K. Koo1, H.J. Kang1, Y.S. Cho2, T.J. Youn2, W.Y. Chung2, I.H. Chae2, D.J. Choi2,H.S. Kim1, B.H. Oh1, Y.B. Park1,Y.S. Choi1

1Seoul National University Hospital, Seoul,South Korea; 2Seoul National UniversityBundang Hospital, Seongnam, Gyeonggi,South Korea

AS-148. Combinational Use ofRosuvastatin with Eprosartan or RamiprilEnhances Inhibition of MonocyteChemoattractant Protein, Interleukin-8,and Cyclooxygenase-2 in EndothelialCells

M.H. Hong, Y.K. Ahn, Y.S. Kim, S.Y. Joo, I.S. Sohn, K.H. Kim, H.W. Park, Y.J. Hong, J.H. Kim, W. Kim, M.H. Jeong, J.G. Cho, J.C. Park


AS-149. Bay 11-7082, an Inhibitor ofNuclear Factor–_B, ImprovesPostischemic Ventricular Dysfunction inRats

S.Y. Joo, Y.K. Ahn, Y.S. Kim, M.H. Hong,I.S. Sohn, K.H. Kim, H.W. Park, Y.J. Hong, J.H. Kim, W. Kim, M.H. Jeong, J.G. Cho, J.C. Park


AS-150. Triflusal versus Aspirin inConjunction with Clopidogrel in PatientsUndergoing Percutaneous CoronaryIntervention with the Drug-Eluting Stent



AS-151. _-Lipoic Acid Inhibits StentRestenosis in a Porcine Coronary StentRestenosis Model

J.H. Kim, M.H. Jeong, Y.J. Hong, K.H. Kim, W. Kim, Y.K. Ahn, J.G. Cho, J.C. Park, J.C. Kang


AS-152. Curcumin Protects Ischemia-Reperfusion Myocardial Injury viaInhibition of Oxidation, Inflammation, andApoptosis

Y.S. Kim, Y.K. Ahn, M.H. Hong, S.Y. Joo, I.S. Sohn, K.H. Kim, H.W. Park, Y.J. Hong, J.H. Kim, W. Kim, M.H. Jeong, J.G. Cho, J.C. Park


AS-153. Randomized Comparison ofCilostazol versus Clopidogrel after Drug-Eluting Stenting in Patients withDiabetes: Cilostazol for Diabetic Patients in Drug-Eluting Stent (CIDES) Trial

Y.K. Ahn1, M.H. Jeong1, T.H. Ahn2, K.J. Oh2,W.C. Kang2, C.G. Park3, J.W. Kim3, J.H. Kim4,I.H. Chae5, C.W. Nam6, S.H. Hur6, J.H. Bae7,K.Y. Kim7, S.K. Oh8, K.H. Yun8

1Chonnam National University Hospital,Gwangju, South Korea; 2Gil Heart Center,Incheon, South Korea; 3Korea UniversityHospital, Seoul, South Korea; 4Busan HanseoHospital , Busan, South Korea; 5Seoul NationalUniversity Hospital, Bundang, South Korea;6Dongsan Medical Center, Daegu, South Korea;7Konyang University Hospital, Daejeon, SouthKorea; 8Wonkwang University Hospital, Iksan,South Korea

AS-154. Protective Effect of Heat ShockProtein 27 Using Protein TransductionDomain-Mediated Delivery on Ischemia-Reperfusion Heart Injury

J.B. Kim1, J.H. Chung2, Y.K. Ko1, D.H. Choi1, Y. Jang1, N. Chung1

1Severance, Seoul, South Korea; 2YonseiCardiovascular Center and CardiovascularResearch Institute, Seoul, South Korea

AS-155. The Effect of Triple AntiplateletTherapy for Prevention of Acute andSubacute Stent Thrombosis after Drug-Eluting Stent Implantation

W. Kim, M.H. Jeong, Y.J. Hong, S.Y. Lim, S.R. Lee, Y.K. Ahn, J.H. Kim, J.G. Cho, J.C. Park, J.C. Kang


AS-156. The Effect of Green Tea onEndothelial Dysfunction and CirculatingEndothelial Progenitor Cells in theChronic Smoker

W. Kim, M.H. Jeong, Y.J. Hong, Y.K. Ahn, J.H. Kim, J.G. Cho, J.C. Kang



AS-162. C-Reactive Protein TriggersInflammatory Activities of HumanVascular Smooth Muscle Cells throughFc_RIIa–Dependent NicotinamideAdenine Dinucleotide PhosphateOxidase Activation

K.H. Han, J.W. Ryu

Asan Medical Center, University of UlsanCollege of Medicine, Seoul, South Korea

AS-163. Intravascular Ultrasound and Intracoronary Biomarkers ofInflammation and/or Atherothrombosis

P. Ohlmann1, O. Morel2, S.W. Kim1, G. Mintz3, E. Escolar1, A.D. Pichard1,D.M. Katz-Sawyer1,L.F. Satler1, K.M. Kent1, W.O. Suddath1, R. Waksman1, N.J. Weissman1

1Washington Hospital Center, Washington, DC,United States; 2Institut d'hématologie etd'Immunologie ULP, Strasbourg, France;3Cardiovascular Research Fondation, New-York, NY, United States

AS-164. Virtual Histology Analysis of Coronary Lesions with PositiveRemodeling

J. Surmely, K. Nasu, H. Fujita, M. Terashima, E. Tsuchikane, T. Matsubara, M. Ehara,T. Ito, Y. Kinoshita, Y. Takeda, N. Tanaka, A. Murata,O. Katoh, T. Suzuki


AS-165. Differences in PlaqueComposition of the Culprit Lesion inAcute Coronary Syndrome Are Relatedto the Risk Category

J. Surmely, K. Nasu, H. Fujita, M. Terashima, E. Tsuchikane, T. Matsubara, M. Ehara, T. Ito,Y. Kinoshita, Y. Takeda, N. Tanaka, A. Murata,O. Katoh, T. Suzuki


AS-166. Statin Therapy Cools DownTemperature of Atherosclerotic Plaque inPatients with Coronary Artery Disease: Temperature Measurement andIntravascular Ultrasound Study

S.Y. Choi, B.J. Choi, S.J. Tahk, M.H. Yoon, S.G. Ahn, H.S. Lim, J.H. Choi, Z.G. Zheng, S.J. Kang, G.S. Hwang, J.H. Shin

Ajou University Hospital, Suwon, Kyoungki,South Korea

AS-167. Pregnancy-Associated PlasmaProtein A and Proform EosinophilicMajor Basic Protein in the Detection ofDifferent Types of Coronary ArteryDisease

P. Hajek, M. Macek, M. Hladikova, B. Houbova, D. Alan, V. Durdil, J. Fiedler, M. Maly, P. Ostadal, J. Veselka

University Hospital Motol, Prague, CzechRepublic

AS-168. Expression of Lectin-LikeOxidized Low-Density LipoproteinReceptor–1 in Autologous Vein Graftsand Vulnerable Vein GraftAtherosclerosis and Modulation byLosartan

D. Huang, J. Ge


BARE METAL STENTThursday, April 27, 2:00~4:00 PM(Abstract nos. 169~177)

AS-169. Short-Term and MidtermOutcomes with the Driver Stent

J. Matsumi, S. Saito, Y. Miyashita, T. Siono, S. Takahashi, H. Domae, H. Kaneda, H. Koga,S. Mizuno, K. Sugitatsu, Y. Minami

Heart Center of Shonan Kamakura GenralHospital, Kamakura, Kanagawa, Japan

AS-170. Clinical and AngiographicPredictors of Restenosis after Bare MetalStent Deployment in Patients withDiabetes

Z.N. Jin, S.Z. Lu, Y.D. Chen


AS-171. The Bolero Spanish Register:Angiographic Follow-Up

J. Moreu1, J.M. Duran5, L. Martinez-Elbal2,L. Insa3, J.L. Delcan4, T. Canton1

1Hospital Virgen de la Salud, Toledo, Spain;2Hospital de la Princesa, Madrid, Spain;3Hospital Clínico, Valencia, Spain; 4Hospital de Monteprincipe, Madrid, Spain;5Hospital Clínico, Valladolid, Spain


AS-157. The Effects of Rosuvastatin onLipoprotein Levels, InflammatoryMarkers, and Plaque Volume in Patientswith Coronary Artery Disease: InterimResults

S.H. Han, K.K. Koh, W.C. Kang, K.J. Oh, W.C. Chung, M.S. Shin, T.H. Ahn, I.S. Choi, E.K. Shin

Gil Hospital, Gachon Medical School , Incheon,South Korea

AS-158. The Effects of Atorvastatin onLong-Term Prognosis in Patients withChronic Heart Failure

R.Q. Xie, W. Cui, F. Liu, Y.M. Hao, X.G. Zu, J. Du


AS-159. The Randomized ComparativeStudy of Using Enoxaparin Instead ofUnfractionated Heparin in theIntervention Treatment of CoronaryArtery Disease (ROUTE)

J. Chen, S. Qiao, Y. Wu, J. Dai, J. Yuan, X. Qin,M. Yao, Y. Yang, R. Gao

Cardiovascular Institute and Fu Wai Hospital,Chinese Academy of Medical Science & PekingUnion Medical College, Beijing, China

AS-160. Use of Statins beforePercutaneous Coronary Intervention withthe Drug-Eluting Stent ReducesPeriprocedural Myonecrosis

H.L. Jen, M.C. Chiang, J.J. Wang, H.W. Pin,A.N. Feng, Y.N. Yang, M.S. Young, W.H. Yin

Cheng-Hsin General Hospital, Taipei, Taiwan

VULNERABLE PLAQUEThursday, April 27, 9:00~11:00 AM(Abstract nos. 161~168)

AS-161. In Vivo Evaluation of Thin-CapFibroatheroma Using Optical CoherenceTomography: Comparison to Angioscopyand Intravascular Ultrasound

Y. Takeda, T. Suzuki, T. Itoh, K. Satoh, H. Fujita,A. Murata, N. Tanaka, K. Nasu, Y. Kinoshita, M. Ehara, M. Terashima, T. Matsubara, O. Katoh


AS-172. Study of Ad Hoc versus PlannedBare Metal Coronary Stenting in Patientswith Stable Angina

T.A. Batyraliev1, N. Guler1, I.V. Pershukov2, E.Y. Moreva2, I.A. Lazarev3, Y.V. Pya1, Z.A. Karben1, T. Seydalieva1, L.N. Petrakova3,D.V. Preobrazhensky3, B.A. Sidorenko3

1Sani Konukoglu Medical Center, Gaziantep,Turkey; 2Regional Clinical Hospital, Voronezh,Russian Federation; 3Presidential MedicalCenter, Moscow, Russian Federation

AS-173. Clinical Outcome after Stentingor Coronary Artery Bypass Surgery forthe Treatment of Left Main CoronaryArtery Disease

J.H. Choi, K.I. Sung, H.C. Gwon, Y.T. Lee, S.H. Lee, P.W. Park, K.P. Hong, J.E. Park


AS-174. Initial and Late Outcomes of theDriver Cobalt Alloy Stent for AcuteCoronary Syndrome

M. Kawamura1, S. Suwa1, S. Miyazaki1, T. Miyazaki1, H. Hayashi1, T. Ichinose1, S. Kojima1, H. Sakurai1, M. Sumiyoshi1, H. Ohta2,T. Kurata2, K. Miyauchi2, H. Daida2

1Juntendo University Shizuoka Hospital,Shizuoka, Japan; 2Juntendo UniversitySchool of Medicine, Tokyo, Japan

AS-175. Feasibility and Safety of LeftMain Coronary Artery Stenting via theRadial Approach: Results from theTAXUS Pilot Study

T. Lefèvre1, P. Pillay1, O. Darremont2, M. Silvestri3, M.C. Morice1, Y. Louvard1, J.L. Leymarie2, P. Garot4, T. Unterseeh4, P. Dumas1

1ICPS, Massy, France; 2Clinique Saint Augustin,Bordeaux, France; 3UCV, Marseille, France;4ICPS, Quincy, France

AS-176. Long-Term (5-Year) Outcomesafter Stenting of Unprotected Left MainCoronary Artery Stenosis in Patients withNormal Left Ventricular Function

B.K. Lee, M.K. Hong, D.W. Park, Y.H. Jeong,E.S. Hwang, S.W. Lee, Y.H. Kim, C.W. Lee, J.J. Kim, S.W. Park, S.J. Park


AS-177. Exaggeration of NeointimalHyperplasia after Bare Metal Stenting

A. Hirohata, M. Murakami, T. Murakami, K. Yamamoto, K. Hina

Cardiovascular Center Sakakibara Hospital,Okayama, Japan

INTRAVASCULAR ULTRASOUNDThursday, April 27, 2:00~4:00 PM(Abstract nos. 178~195)

AS-178. A Volumetric IntravascularUltrasound Comparison of Cypher andTaxus In-Stent Restenosis

P. Ohlmann1, S.W. Kim1, G.S. Mintz2, E. Escolar1, A.D. Pichard1, L.F. Satler1, K.M. Kent1, W.O. Suddath1, R. Waksman1, N.J. Weissman1

1Washington Hospital Center, Washington, DC,United States; 2Cardiovascular ResearchFondation, New York, NY, United States

AS-179. Intravascular UltrasoundPredictors for Side Branch Occlusion inthe Stenting of False Bifurcation Lesions

S.J. Oh, Y.S. Moon, K.H. Kim, B.K. Kim, D.W. Jeon, J.Y. Yang

NHIC Ilsan Hospital, Goyang, Gyeonggi, SouthKorea

AS-180. The Potential of Virtual Histologyand Multidetector-Row ComputedTomography Images for TissueCharacterization of Human CoronaryAtherosclerotic Plaques

R. Funada, Y. Oikawa, J. Yajima, H. Kirigaya, K. Nagashima, O. Shiraiwa, A. Goda, Y. Shiratori, K. Ikeno, H. Sawada, T. Aizawa

The Cardiovascular Institute, Tokyo, Japan

AS-181. Atherosclerotic Plaque Burdenin the Left Main and Ostial Left AnteriorDescending Coronary Arteries in AsianPopulations with AngiographicallyNormal Coronary Arteries: Insights from Volumetric Analysis UsingIntravascular Ultrasound



AS-182. Minimum ContrastPercutaneous Coronary Intervention withIntravascular Ultrasound and Cypher forPatients with Renal Dysfunction WithoutContinuous Hemodialysis

K. Yamazaki, S. Sumitsuji, M. Ihara, H. Nakaoka, M. Satou, M. Okutsu, Y. Nojima, K. Kishida, Y. Nagai

Rinku General Medical Center, Izumisano,Japan

AS-183. Sirolimus-Eluting Stents for thePrevention of Early and Late Lumen Lossin Patients with In-Stent Restenosis:Serial Volumetric IntravascularUltrasound Analysis

H. Yamaguchi, Y. Furusho, S. Toyoshima, K. Kiyonaga, Y. Toyama

Nanpuh Hospital, Kagoshima, Kagoshima,Japan

AS-184. C-Reactive Protein and PlaqueComposition in Patients with StableAngina Pectoris: AnIntravascular Ultrasound–VirtualHistology Study

Y. Matsuo, T. Kubo, S. Ueno, A. Kuroi, T. Yamono, T. Masho, M. Obana, S. Takarada,Y. Hayashi, T. Imanishi, Y. Tomobuchi, T. Akasaka

Wakayama Medical University, Wakayama,Japan

AS-185. Relation Between CoronaryRemodeling and Plaque MorphologyEstimated by Virtual Histology –Intravascular Ultrasound in Patients withAcute Myocardial Infarction

T. Masho, Y. Hayashi, T. Kubo, Y. Tomobuchi,T. Akasaka

Wakayama Medical univercity, Wakayama,Wakayama, Japan

AS-186. Findings of Virtual HistologyAccording to Coronary ArterialRemodeling Patterns

Y. Oikawa, J. Yajima, R. Funada, H. Kirigaya, K. Nagashima, O. Shiraiwa, A. Goda, Y. Shiratori, K. Ikeno, T. Aizawa

The Cardiovascular Institute, Tokyo, Japan


AS-193. Prediction of High-Risk Plaqueof Distal Embolization afterPercutaneous Coronary InterventionAssessed by VirtualHistology–Intravascular Ultrasound

M. Obana, T. Kubo, Y. Matsuo, T. Masho, S. Takarada, Y. Hayashi, T. Imanishi, Y. Tomobuchi, T. Hano, T. Akasaka


AS-194. Follow-Up Low-DensityLipoprotein Cholesterol Level as anIndependent Predictor of Changes inCoronary Atherosclerotic Plaque Size: A Serial Intravascular Ultrasound Analysis

M.K. Hong, C.W. Lee, Y.H. Kim, B.K. Lee, D.W. Park, Y.H. Jeoung, E.S. Hwang, S.W. Lee,D.H. Kang, S.S. Jeoung, J.K. Song, J.J. Kim,S.W. Park, S.J. Park


AS-195. Impact of High-PressureDilatation in Patients with a Left MainTrunk Lesion Treated with the Sirolimus-Eluting Stent: A Quantitative Angiographic andIntravascular Ultrasound Analysis

H. Kaneda, Y. Miyashita, T. Shiono, S. Takahashi, S. Tanaka, H. Domae, H. Koga, J. Matsumi, S. Mizuno, Y. Minami, K. Sugitatsu,H.H. Ye, Y. Taketani, S. Saito

Shonan Kamakura General Hospital, Kamakura, Japan

MISCELLANEOUSThursday, April 27, 2:00~4:00 PM(Abstract nos. 196~229)

AS-196. Formation of a ComplexBetween C-Reactive Protein andLysophosphatidylcholine DecreasesInflammatory Activities and ApoptoticChanges by Vascular Smooth MuscleCells

K.H. Han1, J.W. Ryu1, J.S. Ko1, M.K. Chang2

1Asan Medical Center, University of UlsanCollege of Medicine, Seoul, South Korea;2University of California, San Diego, La Jolla,California, United States


AS-187. Low-Dose Simvastatin InducesPositive Remodeling after CoronaryStenting in Normocholesterolemic Patients

Y.J. Hong, S.R. Lee, M.H. Jeong, W. Kim, J.H. Kim, Y.K. Ahn, J.G. Cho, J.C. Park, J.C. Kang


AS-188. Impact of Final Stent Cross-Sectional Area on Long-Term ResultsAfter Abciximab-Coated StentImplantation

Y.J. Hong, M.H. Jeong, S.Y. Lim, S.R. Lee, W. Kim, J.H. Kim, Y.K. Ahn, J.G. Cho, J.C. Park,J.C. Kang

Chonnam National University Hosptial,Gwangju, South Korea

AS-189. Low Incidence of LateIncomplete Stent Apposition afterAbciximab-Coated Stent Implantation: A Serial Intravascular Ultrasound Analysis

Y.J. Hong, M.H. Jeong, J.H. Kim, W. Kim, Y.K. Ahn, J.G. Cho, J.C. Park, J.C. Kang


AS-190. Limitation of Plaque MappingEstimated by Virtual Histology–Intravascular Ultrasound after CoronaryStent Implantation

Y. Hayashi, T. Kubo, Y. Tomobuchi, T. Akasaka

Wakayama Medical university, Wakayama,Wakayama, Japan

AS-191. Intravascular Ultrasound Analysisof the Relation of Coronary ArterialRemodeling and Plaque Composition

J. Qian, H. Wu, F. Zhang, B. Fan, X. Liu, L. Ge,Y. Lu, J. Ge


AS-192. Impact of IntravascularUltrasound–Guided Drug-Eluting StentImplantation on Angiographic andClinical Outcomes

J.J. Sir1, H.J. Kang1, Y.S. Cho1, T.J. Youn1, W.Y. Chung1, S.H. Kim1, I.H. Chae2, D.J. Choi2,H.S. Kim1, B.H. Oh1, Y.B. PARK1, Y.S. Choi1,B.K. Koo1

1Seoul National University Hospital, Seoul,South Korea; 2Seoul National UniversityBundang Hospital, Seongnam-si, Kyunggi-do,South Korea

AS-197. Serial Changes in the FunctionalSignificance of Jailed Side BranchLesions After Fractional FlowReserve–Guided Side BranchIntervention Strategy in BifurcatingLesions

Y.S. Kim1, J.J. Kwak1, J.J. Sir1, B.K. Koo1, Y.S. Cho2, H.J. Kang1, T.J. Youn2, W.Y. Chung2,I.H. Chae2, D.J. Choi2, H.S. Kim1, B.H. Oh1, Y.B. Park1, Y.S. Choi1

1Seoul National University Hospital, Seoul,South Korea; 2Seoul National UviversityBundang Hospital, Seongnam, Gyeonggi,South Korea

AS-198. Radial Artery Size in AdultIndians

A. Ranjan, N. Tanwar, R. Pothiwala, H. Malhotra, S. Shah, T. Patel

Sterling Hospital, Ahmedabad, Gujarat, India

AS-199. Staphylococcus AureusInfections Complicating PercutaneousCoronary Intervention

J.W. Van Werkum, J.M. Ten Berg, J. Kelder, M. Suttorp, B. Rensing, M. Tersmette

Sint Antonius Hospital, nieuwegein, Utrecht,The Netherlands

AS-200. Femoral Vascular Access SiteComplications with the Use of Angiosealin Patients Undergoing PercutaneousCoronary Intervention Treated withDouble and Triple Antiplatelet Regimensin the Real World

J.W. Van Werkum, A. Heestermans, M.J. Suttorp, B. Rensing, J. Kelder, J.M. Ten berg

Sint Antonius Hospital, Nieuwegein, Utrecht,The Netherlands

AS-201. Clinical Feasibility of theTransradial Approach for Left MainCoronary Artery Intervention

Y.K. Park, J.H. Lee, E.M. Kim, W.I. Chang, M.S. Han, H.S. Park, M.S. Lee, J.H. Park, S.W. Choi, J.O. Jeong, I.W. Seong

Chungnam National University Hospital,Daejeon, South Korea

AS-202. Myocardial Bridging Is Relatedto Endothelial Dysfunction but NotAtherosclerotic Plaque as Assessed byIntracoronary Ultrasound

J.W. Kim, H.S. Seog, S.Y. Suh, S.W. Rha, C.G. Park, D.J. Oh


AS-203. Is It Safe to Use the TransradialApproach For Primary CoronaryIntervention in the Treatment of AcuteST-Segment Elevation MyocardialInfarction?

S.J. Park, J.H. Lee, E.M. Lee, W.I. Chang, M.S. Han, H.S. Park, Y.K. Park, M.S. Lee, J.H. Park, S.W. Choi, J.O. Jeong, I.W. Seong

Chungnam National University Hospital,Daejeon, South Korea

AS-204. Are There Any ProceduralDifferences in the Right and Left RadialApproach in Transradial CoronaryIntervention?

J.Y. Kim, J. Yoon, I.H. Jung, H.S. Wang, H.S. Jung, H.M. Choe, B.S. Yoo, S.H. Lee, K.H. Choe

Wonju Christian Hospital, Wonju, South Korea

AS-205. Clinical Significance ofSuccessful Recanalization in Patientswith Chronic Total Occlusion

H.S. Lee, Y.W. Park, J.Y. Han, H.J. Kang, H.S. Kim, D.H. Yang, H.S. Park, Y.K. Cho, S.C. Chae, J.E. Jun, W.H. Park

Kyungbook University Hospital, Daegu, Daegu,South Korea

AS-206. Positive Remodeling of theCoronary Artery After Recanalization ofCTO Lesions

Y.W. Park, J.Y. Han, H.S. Lee, H.J. Kang, D.H. Yang, H.S. Kim, H.S. Park, Y.K. Cho, S.C. Chae, J.E. Jeon, W.H. Park

Kyungbook University Hospital, Daegu, Daegu,South Korea

AS-207. Coronary Stent ImplantationDecreased Plasma N-Terminal Pro-BrainNatriuretic Peptide Levels in Patientswith Preserved Left Ventricular Function

J.S. Park, Y.J. Kim, H.J. Kim, D.G. Shin, B.S. Shim, G.R. Hong

Yeungnam University Hospital, Daegu, SouthKorea

AS-208. Plasma Osteoprotegerin Levelas a Biochemical Marker ofAtherosclerosis in Patients with CoronaryArtery Disease

C.S. Park, W.S. Chung, H.J. Yoon, D.H. Lee,Y.S. Choi, J.H. Kim, H.J. Yoon, Y.J. Shin, S.H. Rhim, H.K. Jeon, Y.S. Oh, D.S. Jeon, S.H. Baek, J.H. Kim, K.B. Choi, S.J. Hong

St Mary's Hospital, Seoul, South Korea

AS-209. The Prognostic Factor ofMyocardial Bridge in a Single Center

D.G. Kang, Y.A. Kim, S.U. Lee, S.K. Cho

Kwangju Christian Hospital, Gwangju, SouthKorea

AS-210. Diagnostic Transradial CoronaryAngiography Without Heparin

J.K. Kim1, J.H. Kim1, S.H. Lee1, S.M. Park1,H.K. Hwang2

1Sun General Hospital, Daejeon, Chungnam,South Korea; 2Sejong General Hospital,Bucheon, Gyunggi, South Korea

AS-211. Value of IntracardiacEchocardiography in Real-TimeMonitoring of the Formation of CardiacThrombus During RadiofrequencyCatheter Ablation of Atrial Fibrillation

X.G. Qin, C.J. Guo, J.C. Zhang, X. Chen

The First Affiliated Hospital, TsinghuaUniversity, Beijing, China

AS-212. Clinical and HereditaryCharacteristics of Long QT Syndrome in258 Cases from 28 Families

X.G. Qin, D.Y. Hu, J.C. Zhang, C.L. Li, P. Li

The First Affiliated Hospital, Tsinghua University,Beijing, China

AS-213. Impact of the MetabolicSyndrome on the Extent of CoronaryAtherosclerosis and CardiovascularEvents

S.G. Ahn, S.J. Tahk, J.H. Choi, H.S. Lim, S.J. Kang, B.J. Choi, S.Y. Choi, M.H. Yoon, J.H. Shin

Department of Cardiology, Ajou UniversityMedical Center, Suwon, South Korea

AS-214. Sequential Deployment Does Not Always Guarantee EvenExpansion of Stents in Kissing Stenting:Benchtop Insight Using CoronaryPhantom

S.J. Oh, Y.S. Moon, B.K. Kim, D.W. Jeon, J.Y. Yang

NHIC Ilsan Hospital, Goyang, Gyeonggi, SouthKorea

AS-215. The Relation Between RiskFactors and the Incidence of CoronaryArtery Stenosis in Patients with ValvularHeart Disease

K.H. Lee, P.W. Park, Y.Y. Jung, Y.T. Lee, K.H. Park, Y.K. Ha


AS-216. N-Terminal Pro-B-TypeNatriuretic Peptide Predicts In-StentRestenosis in Asymptomatic Patientswith Preserved Left Ventricular SystolicFunction

S.N. Hong, Y.K. Ahn, K.H. Kim, I.S. Sohn, H.W. Park, Y.J. Hong, J.H. Kim, W. Kim, M.H. Jeong, J.G. Cho, J.C. Park


AS-217. The Inflammatory Reaction atSites of Overlapping Sirolimus- andPaclitaxel-Eluting Stents in the PorcineIn-Stent Restenosis Model

S.Y. Lim, M.H. Jeong, Y.K. Ahn, J.H. Kim, W. Kim, J.C. Kang


AS-218. Complete CoronaryRevascularization CombiningEndoscopic Bypass Grafting with Drug-Eluting Stent Implantation in 1 Procedure

G. Friedrich, N. Bonaros, T. Schachner, G. Laufer, O. Pachinger, J. Bonatti

University Hospital Innsbruck, Innsbruck,Austria

AS-219. A Study of 75,088 CardiacCatheterizations: Outcomes andComplications

T.A. Batyraliev1, I.V. Pershukov2, N. Guler1, B. Dokumaci1, Z.A. Karben1, F. Besnili1, A. Sercelik1, E.Y. Moreva2

1Sani Konukoglu Medical Center, Gaziantep,Turkey; 2Regional Clinical Hospital, Voronezh,Russian Federation


AS-226. Aminoterminal Propeptide ofType III Procollagen and Severity ofCoronary Artery Disease in PatientsWithout Myocardial Infarction

Y.H. Lin1, Y.L. Ho2, T.D. Wang2, C.P. Liu3, H.L. Kao2, C.L. Chao2, W.J. Chen2

1National Taiwan University Hospital Yun-LinBranch, Yun-Lin, Taiwan; 2National TaiwanUniversity Hospital , Taipei, Taiwan; 3 Yuan’sGeneral Hospital , Kaoshung, Taiwan

AS-227. The Role of Bradykinin andOpioid Receptors in RemotePreconditioning Induced by SkeletalMuscle Ischemia

R.Q. Xie, W. Cui, Y.M. Hao, F. Liu, J. Du, B.H. Li


AS-228. The Change of Low-DensityLipoprotein Particle Size After CoronaryStent Implantation Can Be a Predictor ofRestenosis

J.S. Kim, H.M. Kown, B.K. Hong, Y.W. Yoon,M.H. Kim, S.J. Yoon, H.C. Je, H.S. Kim

Yong-Dong Severance Hospital, Seoul, SouthKorea

AS-229. Learning Curve of TransradialCoronary Angiography via Small-CaliberRadial Artery: A Single Operator’s Experience inChinese Patients

T.S. Tse, K.L. Tsui, C.K. Chan, W.C. Ko, M.C. Choi, K.K. Chan, S.K. Li

Pamela Youde Nethersole Eastern Hospital,Hong Kong, Hong Kong Special AdministrativeRegion of China

NEW INTERVENTIONAL DEVICEThursday, April 27, 2:00~4:00 PM(Abstract nos. 230~233)

AS-230. Percutaneous Patent DuctusArteriosus Closure Using the Chinese

S.I. Dani, S.S. Thanvi, J.S. Prajapati, S.R. Jain, H.R. Joshi, S. Ghosh, K. Sharma, H. Shah, J. Shah, A. Jain, T. Madan, M. Bansal

Department of Cardiology,U.N.Mehta Instituteof Cardiology, Ahmedabad, Gujarat, India

AS-231. Relationship between CoronaryCollateral Circulation and IschemicPreconditioning during PercutaneousCoronary Intervention

T. Yamano, A. Kuroi, S. Takarada, T. Kubo, Y. Tomobuchi, T. Akasaka


AS-232. Comparison of CoronaryCollateral Flow between Stable andUnstable Angina Pectoris

A. Kuroi, T. Yamano, S. Takarada, T. Kubo, Y. Tomobuchi, T. Akasaka


AS-233. Local Delivery of Paclitaxel afterCoronary Stent (PACS) Protocol

R.S. De Moura1, F.V. Barreto1, M.S. Costa1, F.S. Tavares1, G.V. Oliveira2, J.G. Amino3, L.M. Brasileiro3, S. Murad-Netto2

1Instituto do Coração e da Criança do Rio deJaneiro, Rio de Janeiro, RJ, Brazil; 2Instituto dePós Graduação Médica do Rio de Janeiro, Riode Janeiro, RJ, Brazil; 3Hospital Balbino, Rio deJaneiro, RJ, Brazil

AS-220. A Serious Complication of a Power Injector for CoronaryAngiography

H. Kaneda, S. Tanaka, Y. Miyashita, T. Shiono,S. Takahashi, Y. Taketani, H. Domae, H. Koga,J. Matsumi, S. Mizuno, Y. Minami, K. Sugitatsu,H.H. Ye, S. Saito


AS-221. Outcomes of Fractional FlowReserve–Guided Jailed Side BranchIntervention in Bifurcation Lesions

B.K. Koo, H.J. Kang, Y.S. Cho, W.Y. Chung,I.H. Chae, D.J. Choi, H.S. Kim, B.H. Oh, Y.B. Park


AS-222. The Role of Ischemic ModifiedAlbumin as an Early, Sensitive Marker ofTransient Myocardial Ischemia

M.J. Kim

Keimyung University, Dae-gu, South Korea

AS-223. Predictors of FunctionallySignificant Side Branch Jailing afterDrug-Eluting Stent Implantation

S.J. Hwang, H.J. Kang, Y.S. Cho, T.J. Yeon,W.Y. Chung, I.H. Chae, D.J. Choi, H.S. Kim,D.W. Sohn, B.H. Oh, Y.B. Park, Y.S. Choi, .K. Koo


AS-224. Less Revascularization inPatients with Diabetes Mellitus withSilent Myocardial Ischemia Results inPoor Survival Compared with Patientswith Diabetes with SymptomaticCoronary Artery Disease

E.K. Choi, B.K. Koo, Y.S. Cho, H.J. Kang, W.Y. Chung, T.J. Youn, I.H. Chae, D.J. Choi,H.S. Kim, B.H. Oh, Y.B. Park, Y.S. Choi

Seoul National University Hospital, Seoul,South Korea

AS-225. Radial Access for Reduction ofCost in Interventional Cardiology

J.A. Gaspar, D. Fiandra, A. Fiandra, B. Erramun, C. Pardinas, A. Firszt, J. Musetti, F. Urrutia, S. Lopez

INCC, Montevideo, Uruguay


PERIPHERAL INTERVENTIONThursday, April 27, 2:00~4:00 PM(Abstract nos. 234~246)

AS-234. Transradial Subclavian ArteryInterventions

N. Tanwar, S. Shah, F. Panchal, S. Gupta, H. Malhotra, A. Ranjan, T. Patel


AS-235. Transradial Iliac ArteryInterventions

S. Shah, N. Tanwar, A. Ranjan, K. Jani, H. Malhotra, S. Gupta, T. Patel


AS-236. PTA for Below-the-Knee Arteries

H. Shinji, M. Shiba, H. Itaya, M. Nakamura

Toho University Medical Center OhashiHospital, meguro-ku, Tokyo, Japan

AS-237. Combination of Mild RenalInsufficiency and Peripheral ArteryDisease Accelerate Long-Term EventRisk in Patients with Chest Pain

H. Itaya, M. Shiba, S. Hideo, M. Nakamura

Toho Medical Center Ohashi Hospital, Tokyo,Japan

AS-238. Renal Frame Counts after RenalArtery Stent Placement Can Predict theRecovery of Renal Function

M. Shiba, M. Nakamura, H. Itaya, H. Shinji, K. Makino, M. Wada

Toho University Ohashi Medical Center, Tokyo,Japan

AS-239. Safety and Feasibility of the 2-Wire Technique in Protected CarotidArtery Stenting

Y. Yokoi, O. Kawarada, S. Nakata, N. Morioka

Kishiwada Tokushukai Hospital, Kishiwada,Osaka, Japan

AS-240. The Relationship betweenPressure Gradient, QuantitativeAngiography Analysis, and DuplexUltrasonography for the Detection ofSignificant Renal Artery Stenosis

O. Kawarada, Y. Yokoi, N. Morioka, S. Nakata

Kishiwada Tokushukai Hospital, Kishiwada,Osaka, Japan

AS-241. Carotid Stenting in Candidatesfor Coronary Artery Bypass Surgery: Results of a Heart Hospital Registry

S.E. Kassaian, D. Kazemisaleh, M. Alidoosti, M. Salarifar, A.M. Hajizeinali, E. Hakki, A.M. Sahraian, M.R. Gheini, S.H. Abbasi

Tehran Heart Center, Tehran, Iran

AS-242. The Role of Inflammation in thePredictor of Mortality of Patients withType B Acute Aortic Syndrome

W. Kim, M.H. Jeong, Y.J. Hong, J.H. Kim, J.C. Park, J.G. Cho, J.C. Kagn, Y.K. Ahn


AS-243. Efficacy of SubintimalAngioplasty in Multisegmental LongOcclusive Lesions of Lower LimbArteries Inappropriate for SurgicalTreatments

J.S. Kim, C.M. Ahn, Y.G. Ko, D. Choi, Y. Jang,N.S. Chung, W.H. Shim, S.Y. Cho

Division of Cardiology, Yonsei CardiovascularCenter, Yonsei University College of Medicine,Seoul, South Korea

AS-244. Intravascular Ultrasound GuidedRenal Artery Stenting Shows DecreasedRestenosis

J.H. Lee1, S.H. Park2

1Carle Foundation Hospital, University of Illinois,School of Medicine, Urbana, Illinois, UnitedStates; 2Carle Clinic, Heart Center, Urbana,Illinois, United States

AS-245. Minimally Invasive Renal ArteryStenting: Results of a Large Single-Center Study

T. Lefèvre, V. Decalf, Y. Louvard, P. Garot, T. Unterseeh, O. Tavolaro, M.C. Morice

ICPS, Massy, France

AS-246. Influence of Lesion Length onRestenosis after Vertebral Artery OriginStenting

Y.H. Lin1, Y.C. Liu2, C.S. Hung2, J.M. Juang1,H.L. Kao2

1National Taiwan University Hospital Yun-LinBranch, Yunlin, Taiwan; 2National TaiwanUniversity Hospital , Taipei, Taiwan

VALVULAR HEART DISEASEThursday, April 27, 2:00~4:00 PM(Abstract nos. 247~250)

AS-247. Percutaneous Closure of Mitraland Aortic Perivalvular Leak withAmplatzer Duct Occluder

E. Garcia, T. Datino, M. Abeytua, F. Sarnago

Gregorio Marañón, Madrid, Spain

AS-248. Balloon Mitral Valvuloplasty inPatients < 20 Years of Age: Acute andIntermediate Results

S.I. Dani, S.S. Thanvi, J.S. Prajapati, H.R. Joshi, S.R. Jain, S. Ghosh, K. Sharma, H.Shah, J. Shah, A. Jain, T. Madan, M. Bansal

U.N.Mehta Institute of Cardiology andResearch Centre, Ahmedabad, Gujarat, India

AS-249. Six Cases of Tricuspid BalloonValvuloplasty

S. Cha, T. Ng, S. Sumathisena, R. Bender, C.Dennis

Deborah Heart & Lung Center, Browns Mills,NJ, United States

AS-250. Balloon Mitral Valvuloplasty inCases with Left Atrial Appendage (LAA)Thrombus

R.S. Shinde, S.V. Sathe, A.S. Sathe, C.N. Makhle, A.C. Mehta, P.K. Grant , M.S. Hiremath, M. Durairaj

Ruby Hall Clinic, Grant Medical Foundation,Pune, Maharashtra, India


We, CVRF, would like to extend our deepest appreciation to the abstract graders of Angioplasty Summit 2006-TCT Asia Pacific. The lavish contributions in their time and expertise make this scientific meeting more educational and fertilized.

Abstract Graders_

Alexandre Abizaid, MDInstituto Dante Pazzanese of Cardiologia, Brazil

Maurice Buchbinder, MDFoundation for Cardiovascular Medicine, USA

In-Ho Chae, MDSeoul National University Hospital, Korea

Kenneth Chin, MDPantai Medical Centre, Malaysia

Antonio Colombo, MDColumbus Hospital, Italy

Junbo Ge, MDZhongshan Hospital, China

Eberhard Grube, MDHeart Center Siegburg, Germany

Hyeon-Cheol Gwon, MDSamsung Medical Center, Korea

Yaling Han, MDShenyang Northern Hospital, China

Mun Kyung Hong, MDNew York Presbyterian Hospital, USA

Myeong-Ki Hong, MDAsan Medical Center, Korea

Jui-Sung Hung, MDChina Medical University Hospital, Taiwan

Yong Huo, MDFirst Hospital Peking University, China

Ik-Kyung Jang, MD Massachusetts General Hospital, USA

Yang-Soo Jang, MDYonsei University Severance Hospital, Korea

Myung-Ho Jeong, MDChonnam National University Hospital, Korea

Paul Hsien-Li Kao, MDNational Taiwan University Hospital, Taiwan

Osamu Katoh, MDToyohashi Heart Center, Japan

Hyo-Soo Kim, MDSeoul National University Hospital, Korea

Jae-Joong Kim, MDAsan Medical Center, Korea

Young-Hak Kim, MDAsan Medical Center, Korea

Takeshi Kimura, MDKyoto University Hospital, Japan

Jae-Ki Ko, MDChonbuk National University Hospital, Korea

Cheol-Whan Lee, MDAsan Medical Center, Korea

Sang Hoon Lee, MDSamsung Medical Center, Korea

Yean-Leng Lim, MDThe University of Melbourne, Australia

Gary S. Mintz, MDCardiovascular Research Foundation, USA

Kazuaki Mitsudo, MDKurashiki Central Hospital, Japan

Toshiya Muramatsu, MDKawasaki Social Insurance Hospital, Japan

Masahiko Ochiai, MDShowa University Hokubu Hospital, Japan

Byung-Hee Oh, MDSeoul National University Hospital, Korea

John A. Ormiston, MDMercy Hospital, New Zealand

Seong-Wook Park, MDAsan Medical Center, Korea

Seung-Jung Park, MDAsan Medical Center, Korea

Shigeru Saito, MDShonan Kamakura General Hospital, Japan

Teguh Santoso, MDUniversity of Indonesia Medical School, Indonesia

Ashok Seth, MDMax Devki Devi Heart & Vascular Institute, India

Ki Bae Seung, MDThe Catholic University of Korea, St. Mary'sHospital, Korea

Takahiko Suzuki, MDToyohashi Heart Center, Japan

Seung-Jea Tahk, MDAjou University Medical Center, Korea

Hideo Tamai, MDShiga Medical Center for Adults, Japan

Etsuo Tsuchikane, MDToyohashi Heart Center, Japan

Tetsu Yamaguchi, MDToranomon Hospital, Japan

Alan C. Yeung, MDStanford University Medical Center, USA

Junghan Yoon, MDYonsei University Wonju Christian Hospital, Korea

Robaayah Zambahari, MDNational Heart Institute, Malaysia

44 l 45 Poster Abstract Presentations / Abstract Graders

Acknowledgement_

Commercial Support

Academic Program

CardioVascular Research Foundation(CVRF)

Kyung-Ae Kim, RN, Meeting Planner, Academic ProgramsChesil Lee, Manager, Academic Programs, Exhibitor Services

Soon-Jung Rho, Manager, Website, Graphic DesignMi-Jeong Kim, Manager, Accounting Development

Mi-Kyung Jung, Executive Assistant to Seung-Jung Park, MD

Cardiac Catheterization Laboratory,Asan Medical Center

Jae Yun Ko, RT, Director, Video Production ServicesMin Suk Lee, RT, Manager, Network Services

Kang-Soo Jung, RT, Manager, Video Production Services

Soon Deok Jang, RTHea Young Jo, NA

Hyo jin Kim, RNEun Jeong Lee, RN

Hyun Kyung Park, RNJin Seok Roh, RT

Hea Young Yun, RN

Deok Cheol Jeong, RTHo Jung Kim, RTJu Hee Kim, RN

Jung Sook Oh, RNJi Yeon Park, NA

Young Suk Yoo, RN

Myeong-Ki Hong, MDYoung-Hak Kim, MDCheol-Whan Lee, MDSeung-Whan Lee, MDJae Hyeong Park, MD

Hyun Sook Kim, MDBong-Ki Lee, MD

Jae-Hwan Lee, MDDuck Woo Park, MD

Major BenefactorsJohnson & Johnson Medical Korea

Boston Scientific KoreaMedtronic, Inc.

BenefactorsAstraZeneca Korea

Boryung Pharrm.Co., LTD.Bristol-Myers Squibb Korea & Sanofi Aventis

GE Healthcare Bio-SciencesGuerbet Korea

Hanmi Pharmaceutical Co.LTD.Korea Otsuka Pharmaceutical

MSD KoreaOrbusNeich Medical Korea, Ltd.Pfizer Pharmaceutical Korea Ltd.

TERUMO KOREA CORPORATION

ContributorsWe, CVRF, wish to express our special gratitude to the following

contributors and the dedicated individuals for Angioplasty Summit 2006-TCT Asia Pacific.

Their unrestricted efforts and passions on this meeting for one year have come up with this distinctive meeting.

CVRF wishes to extend special appreciations to the following companies for the support of their

educational grants and participation in the Angioplasty Summit 2006-TCT Asia Pacific.

46 l 47 Acknowledgement / Exhibit / Learning Center Lay-Out

Exhibit/Learning Center Lay-Out_The CVRF wishes to express our sincere appreciations to the following companies for the support of their educational grants and participation in the Angioplasty Summit 2006-TCT Asia Pacific meeting

Exhibit Location W-Hotel, Outdoor Exhibit Hall, Level B3

Exhibit Hours Wednesday, April 26, 9:00AM- 6:00PMThursday, April 27, 9:00AM- 6:00PMFriday, April 28, 9:00AM- 12:30PM

A 1 GlaxoSmithKlineA 2 KorMedics Life SystemA 3 Hyundai Pharm Ind.Co., LtdA 4 DatascopeA 5 Guerbet KoreaA 6 GE Healthcare Bio-Sciences A 7 Bristol-Myers Squibb Korea & Sanofi AventisA 8 OrbusNeich Medical KoreaA 9 Goodman Korea Co., LtdA 10 Intek Technology S.A.A 11 VASOCARE Co., LtdA 12 LG Life Sciences Co., LtdA 13 CARDIOTEC Co., LtdA 14 KMB PharmB 1 MSD KOREAB 2 Hanmi Pharmaceutical Co., LtdB 3 Guidant CorporationB 4 Boston Scientifics, LtdB 5 Johnson&Johnson Medical KoreaB 6 Medtronic, Inc.B 7 Biosensors International Pte Ltd

B 8 Terumo Korea CorporationC 1 BT+C 2 B.Braun KoreaC 3 Unipharm KoreaC 4 CHONG KUN DANGC 5 St. Jude MedicalC 6 Novartis Korea Ltd. C 7 Boryung Pharm Co., LtdC 8 AMG KOREA Co., LtdC 9 Korea Otsuka PharmaceuticalC 10 AstraZeneca KoreaC 11 Pfizer Pharmaceutical Korea Ltd.C 12 Siemens MedicalC 13 PAVMEDC 14 Sanofi-Aventis KoreaC 15 Schering KoreaC 16 HANDOK Pharmaceuticals Co., LtdC 17 Abbott Korea LtdC 18 Kunwha PharmaceuticalC 19 Philips Medical SystemsC 20 Kyung Poong Pharmaceutical Co., Ltd

Booth No. Company Name Booth No. Company Name

- Learning Center: Interventional Vascular Simulation Center /IVUS Center

- Information- Shuttle Bus- Book Selling Desk- Lunch Boxes

Exhibit Hall / Learning CenterPoster Abstract Presentations

B3F_

Venue Lay-Out_W-HOTEL

Main Arena- Plenary Sessions and Live Case Transmissions

Free Function- Registration & Bag Pick Up- CVRF Booth(Secretariat)- Educational Booth- Future Meeting Desk- Cyber Station- Translation Receiver Distribution

Information Desk

Registration Booths

B2F_ VISTA HALL

- Facilities for Faculty- Faculty Registration- Faculty Lunch

B1F_Faculty Lounge (Ida)

Room 4-1(Art Center)- Breakfast Meetings

Lunchtime ActivitiesRoom 4-2(Pine Room)- Meeting RoomRoom 4-3(Oak Room)- Press Room

Room3-1(Cosmos)- Breakfast Meetings

Lunchtime ActivitiesRoom3-2(Daffodi)- Meeting RoomRoom3-3(Orchid)- Staff Room

3F_

Room 2-1(Presidio Room) - Breakfast Meetings

Lunchtime Activities Room2-2(Studio Room)- Breakfast Meetings

Lunchtime Activities- Access to COMBAT Meeting- APSIC AB Meeting

2F_

SHERATON GRANDE WALKERHILL HOTEL

Tutorial Auditorium A - Technical Forums

State of the Art Lectures / Live Case Transmissions- Breakfast Meetings- Lunchtime Activities- Evening Symposia

Tutorial Auditorium B - Hot Topic Series- Exclusive International Meeting Sessions- Evening Symposia- Breakfast Meetings- Lunchtime Activities

Translation Receiver Distribution DeskInformation Desk

Preview Room- Calla Room

1F_TUTORIAL AUDITORIUMMUGUNGHWA GRAND BALLROOM

AB

4F_

48 l 49 Venue Lay-Out

seoul, april 25-27, 2007 · seoul, april 25-27, 2007 “please block the dates on your...

Documents